Publication Count – 2015

Chapters in books

  1. Gabriels, G.A. 2015. Nutritional supplement commodification and consequence to sport. In D. Chatziefstathiou and A.K. Talentino (eds), Sporting Boundaries, Sporting Events and Commodification, pp. 75-100. Oxford, UK: Inter-disciplinary Press. ISBN 9781848883888.
  2. Khumalo, N. 2015. Skin disorders. In D.F. Wittenberg (ed), Coovadia's Paediatrics & Child Health, pp. 729-747. 6th edition. South Africa: Oxford University Pess Southern Africa. ISBN 9780195988437.


Encyclopaedia entries

  1. Benatar, S.R. 2015. International Encyclopedia of the Social and Behavioral Sciences in International Encyclopedia of the Social and Behavioral Sciences, pp. 633-639. Netherlands: Elsevier Inc. ISBN 9780080970875.


Peer-reviewed Journals (DoE Accredited)

  • A - E

    1. Abay, E., Van Der Westuizen, J.H., Swart, K.J., Gibhard, L., Lawrence, N., Dambuza, N., Wiesner, L., Wilhelm, A. and Pravin, K. 2015. Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model. Malaria Journal, 14: 8(7pp).
    2. Abdissa, A., Olsen, M.F., Yilma, D., Tesfaye, M., Girma, T., Christiansen, M., Hagen, C.M., Wiesner, L., Castel, S.A., Aseffa, A., McIlleron, H., Pedersen, C., Friis, H. and Andersen, A.B. 2015. Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients. HIV Medicine, 16: 403-411.
    3. Abraham, S. and Symons, G.J. 2015. Non-pharmacological management of chronic obstructive pulmonary disease. SAMJ South African Medical Journal, 105(9): 789.
    4. Abrahams, M.N. 2015. Gout and hyperuricaemia. SAMJ South African Medical Journal, 105(12): 1078(3pp).
    5. Abrahams, Z., Dave, J.A., Maartens, G. and Levitt, N. 2015. Changes in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African women. AIDS Research and Therapy, 12(24): 1-6.
    6. Adams, M., De Kock, C., Smith, P.J., Land, K.M., Liu, N., Hopper, M., Hsiao, A., Burgoyne, A., Stringer, T., Meyer, M., Wiesner, L., Chibale, K. and Smith, G.S. 2015. Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexes. Dalton Transactions, 44: 2456-2468.
    7. Adams, S., Ehrlich, R.I., Baatjies, R., Van Zyl Smit, R., Said-Hartley, Q.M., Dawson, R. and Dheda, K. 2015. Incidence of occupational latent tuberculosis infection in South African healthcare workers. European Respiratory Journal, 45: 1364-1373.
    8. Adjuik, M.A., Allan, R., Anvikar, A.R., Ashley, E.A., Ba, M.S., Barennes, H., Barnes, K.I., Bassat, Q., Baudin, E., Bjorkman, A. and Bompart, F. 2015. The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: A meta-analysis of individual patient data. BMC Medicine, 13(66): 1-19.
    9. Adler, D., Wallace, M., Bennie, T., Abar, B., Sadeghi, R., Bekker, L., Williamson, A.-L. and Meiring, T. 2015. High risk human papillomavirus persistence among HIV-infected young women in South Africa. International Journal of Infectious Diseases, 33: 219-221.
    10. Adler, Y., Charron, P., Imazio, M., Badano, L.P., Baron-Esquivias, G., Bogaerts, J., Brucato, A., Gueret, P., Klingel, K., Lionis, C., Maisch, B., Mayosi, B.M., Pavie, A., Ristic, A.D., Tenas, M.S., Seferovic, P.M., Swedberg, K. and Tomkowski, W. 2015. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The task force for the diagnosis and management of pericardial diseases of the European society of cardiology (ESC). European Heart Journal, 36: 2921-2964.
    11. Allie, S., Stanley, A., Bryer, A., Meiring, M. and Combrinck, M.I. 2015. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients. International Journal of Stroke, 10(8): 1294–1296.
    12. Allwood, B. and Calligaro, G.L. 2015. Pathogenesis of chronic obstructive pulmonary disease: an African perspective. SAMJ South African Medical Journal, 105(9): 789.
    13. Allwood, B.W., Goldin, J., Said-Hartley, Q.M., Van Zyl-Smit, R., Calligaro, G.L., Esmail, A., Beyers, N. and Bateman, E.D. 2015. Assessment of previous tuberculosis status using questionnaires, chest X-rays and computed tomography scans. International Journal of Tuberculosis and Lung Disease, 19(12): 1435-1440.
    14. Amaral, A.F.S., Coton, S., Kato, B., Tan, W.C., Studnicka, M., Janson, C., Gislason, T., Mannino, D.M., Bateman, E.D., Buist, S.A. and Burney, P.G.J. 2015. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. European Respiratory Journal, 46(4): 1104-1112.
    15. Aminde, L.N., Takah, N.F., Dzudie, A., Bonko, N.M., Awungafac, G., Teno, D., Mbuagbaw, L. and Sliwa, K. 2015. Occupational post-exposure prophylaxis (PEP) against human immunodeficiency virus (HIV) infection in a health district in Cameroon: Assessment of the knowledge and practices of nurses. PLoS One, 10(4): e0124416(12pp).
    16. Andrews, J.R., Hatherill, M., Mahomed, H., Hanekom, W.A., Campo, M., Hawn, T., Wood, R. and Scriba, T.J. 2015. The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents. American Journal of Respiratory and Critical Care Medicine, 191(5): 584-591.
    17. Antel, K.R., Singh, N., Chisholm, B.S. and Heckmann, J.M. 2015. Encephalopathy after persistent vomiting: three cases of non-alcohol-related Wernickes encephalopathy. SAMJ South African Medical Journal, 105(6): 442-443.
    18. Antel, K.R., Panieri, E. and Novitzky, N. 2015. Role of splenectomy for immune thrombocytopenic purpura (ITP) in the era of new second-line therapies and in the setting of a high prevalence of HIV-associated ITP. SAMJ South African Medical Journal, 105(4): 408-412.
    19. Ataklte, F., Erqou, S., Kaptoge, S., Taye, B., Echouffo-Tcheugui, J.B. and Kengne, A.P. 2015. Burden of undiagnosed hypertension in Sub-Saharan Africa: a systematic review and meta-analysis. Hypertension, 65: 291-298.
    20. Atiase, Y., Farni, K., Plange-Rhule, J., Luke, A., Bovet, P., Forrester, T.E., Lambert, E.V., Levitt, N., Kliethermes, S., Cao, G., Durazo-Arvizu, R.A., Cooper, R.S. and Dugas, L. 2015. A comparison of indices of glucose metabolism in five black populations: data from modeling the epidemiologic transition study (METS). BMC Public Health, 15: 895(10pp).
    21. Atkinson, P., Bowra, J., Lambert, M., Lamprecht, H., Noble, V. and Jarman, B. 2015. International Federation for emergency Medicine point of care ultrasound curriculum. Canadian Journal of Emergency Medicine, 17(2): 161-170.
    22. Ayina, C.N.A., Sobngwi, E., Essouma, M., Noubiap, J.J., Boudou, P., Ngoa, L.S.E. and Gautier, F. 2015. Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity. Diabetology & Metabolic Syndrome, 7: 47(4pp).
    23. Bachmann, M.O., Timmerman, V. and Fairall, L. 2015. Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion. AIDS, 29(17): 2261-2268.
    24. Barnes, K.I., Workman, L., Ashley, E.A., Aweeka, F. and Bassat, Q. 2015. Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data. BMC Medicine, 13: 227(19pp).
    25. Barnes, K.I., Abdulla, S., Adam, I. and d'Alessandro, U. 2015. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC Medicine, 13: 212(16pp).
    26. Barnes, K.I., Workman, L., Anstey, N., Price, R.N. and Davis, T.M.E. 2015. The effect of dose on the antimalarial efficacy of artemetherlumefantrine: a systematic review and pooled analysis of individual patient data. Lancet Infectious Diseases, 15: 692-702.
    27. Barth, D., Zuhlke, L., Joachim, A., Hoegger, T., Mayosi, B.M. and Engel, M.E. 2015. Effect of distance to health facility on the maintenance of INR therapeutic ranges in rheumatic heart disease patients from Cape Town: no evidence for an association. BMC Health Services Research, 15: 219(7pp).
    28. Barth, D., Mayosi, B.M., Jabar, A. and Engel, M.E. 2015. Prevalence of group a streptococcal disease in North and Sub-Saharan Africa: a systematic review protocol. BMJ Open, 5: e008646(5pp).
    29. Basera, W., Botha, M., Gray, C.L., Lunjani, N., Watkins, A., Venter, c., Allen, K.J., Hlela, C., Zar, H.J. and Levin, M. 2015. The South African food sensitisation and food allergy population-based study of IgE-mediated food allergy: validity, safety, and acceptability. Annals of Allergy Asthma & Immunology, 115: 113-119.
    30. Bateman, E.D., Jithoo, A., Adams, D., Barnes, E., Freeman, J., Hayes, A., Hlengwa, S., Johannisen, C., Koopman, M., Louw, I., Ludick, I. and Storbeck, J. 2015. Gaps in using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites. International Journal of Tuberculosis and Lung Disease, 19(1): 21-30.
    31. Bateman, E.D., Chapman, K.R., Singh, D., D'Urzo, A., Molins, E., Leselbaum, A. and Gil, E.G. 2015. Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respiratory Research, 16: 92(13pp).
    32. Bateman, E.D., Buhl, R., O'Byrne, P.M., Humbert, M., Reddel, H.K., Sears, M., Jenkins, C., Harrison, T., Quirce, S., Peterson, S. and Eriksson, G. 2015. Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations. Journal of Allergy and Clinical Immunology, 135(6): 1457-1464.
    33. Bateman, E.D., Esser, D., Chirila, C., Fernandez, M., Fowler, A., Moroni-Zentgraf, P. and Fitzgerald, J.M. 2015. Magnitude of effect of asthma treatments on asthma quality of life questionnaire and asthma control questionnaire scores: systematic review and network meta-analysis. Journal of Allergy and Clinical Immunology, 136: 914-922.
    34. Bateman, E.D., Bousquet, P.J., Aubier, M., Bredenbroker, D. and O'Byrne, P. 2015. Roflumilast for asthma: efficacy findings in non-placebo-controlled comparator and dosing studies. Pulmonary Pharmacology & Therapeutics, 35: S11-S19.
    35. Bateman, E.D., Reddel, H.K., Van Zyl Smit, R. and Agusti, A. 2015. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respiratory Medicine, 3: 719-728.
    36. Bateman, K.J., Rogers, C. and Meyer, E. 2015. An approach to acute vertigo. SAMJ South African Medical Journal, 105(8): 694-695.
    37. Beale, M.A., Sabiit, W., Robertson, E.J., Fuentes-Cabrejo, K.M., O'Hanlon, S.J., Jarvas, J.N., Loyse, A., Meintjes, G., Harrison, T., May, R.C., Fisher, M.C. and Bicanic, T. 2015. Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across Southern Africa. PLoS Neglected Tropical Diseases, 9(6): e0003847(18pp).
    38. Bedeker, W., Lachman, A.S., Borkum, M., Hellenberg, D.A. and Cupido, C. 2015. Impact of transthoracic echocardiography at district hospital level. SAMJ South African Medical Journal, 105(10): 817-822.
    39. Bekker, L., Johnson, L.F., Cowan, F.M., Overs, C., Besada, D., Hillier, S. and Cates, W. 2015. Combination HIV prevention for female sex workers: what is the evidence? Lancet, 385: 72-87.
    40. Bekker, L., Johnson, L.F., Wallace, M. and Hosek, S. 2015. Building our youth for the future. Journal of the International AIDS Society, 18: 20027(7pp).
    41. Bekker, L., Gill, K. and Wallace, M. 2015. Pre-exposure prophylaxis for South African adolescents: what evidence? SAMJ South African Medical Journal, 105(11): 907-911.
    42. Belard, S., Heuvelings, C., Janssen, S. and Grobusch, M. 2015. Bedaquiline for the treatment of drug-resistant tuberculosis. Expert Review of Anti-infective Therapy, 13(5): 535-553.
    43. Benatar, S.R. 2015. The humanistic side of medical education. SAMJ South African Medical Journal, 105(1): 3-3.
    44. Benatar, S.R. 2015. Reflections on ethical challenges associated with the Ebola epidemic. SAMJ South African Medical Journal, 105(12): 1012-1013.
    45. Bernstein, D.I., Bateman, E.D., Woodcock, A., Toler, W., Forth, R., Jacques, L., Nunn, C. and O'Byrne, P.M. 2015. Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma. Journal of Asthma, 52(10): 1073-1083.
    46. Beyrer, C., Crago, A., Bekker, L., Butler, J., Shannon, K., Kerrigan, D., Decker, M.R., Baral, S., Poteat, T. and Wirtz, A.L. 2015. An action agenda for HIV and sex workers. Lancet, 385: 287-301.
    47. Bicanic, T., Bottomley, C., Loyse, A., Brouwer, A., Muzoora, C., Taseera, K., Jackson, A., Phulusa, J., Hosseinipour, M., van der Horst, C., Limmathurotsakul, D., White, N., Wilson, D., Wood, R., Meintjes, G., Harrison, T.S. and Jarvis, J.N. 2015. Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis. Antimicrobial Agents and Chemotherapy, 59(12): 7224-7231.
    48. Bigna, J.J., Noubiap, J.J., Agbor, A.A., Plottel, C.S., Billong, S.C., Ayong, A.P. and Koulla-Shiro, S. 2015. Early mortality during initial treatment of tuberculosis in patients co-infected with HIV at the Yaounde Central Hospital, Cameroon: an 8-year retrospective cohort study (2006-2013). PLoS One, 10(7): e0132394(13pp).
    49. Blockman, M. 2015. Adverse drug events - why we care. Current Allergy & Clinical Immunology, 28(4): 248-250.
    50. Blom, D. 2015. South African Dyslipidaemia Guideline Consensus Statement: a joint statement from the South African Heart Association (SA Heart) and the Lipid and Atherosclerosis Society of Southern Africa (LASSA). South African Family Practice (Geneeskunde: The Medicine Journal), 57(2): 22-31.
    51. Blom, D., Djedjos, C.S., Monsalvo, M.L., Bridges, I., Wasserman, S.M., Scott, R. and Roth, E. 2015. Effects of evolocumab on vitamin E and steroid hormone levels: results from the 52-week, phase 3, double-blind, randomized, placebo-controlled Descartes study. Circulation Research, 117: 731-741.
    52. Bloomfield, G., Alenezi, F., Barasa, A.F., Lumsden, R., Mayosi, B.M. and Velazquez, E.J. 2015. Human immunodeficiency virus and heart Failure in low- and middle-income countries. JACC: Heart Failure, 3(8): 579-590.
    53. Boeree, M.J., Diacon, A., Dawson, R., Narunsky, K., Du Bois, J., Venter, A., Phillips, P.P.J., Gillespie, S., McHugh, T., Hoelscher, M., Heinrich, N., Rehal, S. and PanACEA Consortium, P. 2015. A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis. American Journal of Respiratory and Critical Care Medicine, 191(9): 1058-1065.
    54. Boggild, A.K., Esposito, D.H., Kozarsky, P.E., Ansdell, V., Beeching, N.J., Campion, D., Castelli, F., Caumes, E., Chappuis, F., Cramer, J.P., Gkrania-Klotsas, E., Grobusch, M.P., Hagmann, S., Hynes, N.A., Lim, P.L., Lopez-Velez, R., Malvy, D.J.M., Mendelson, M., Parola, P., Sotir, M., Wu, H.M. and Hamer, D.H. 2015. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the geosentinel surveillance network. Annals of Internal Medicine, 162: 757-764.
    55. Bohm, M., Schumacher, H., Linz, D., Reil, J.-C., Lonn, E., Teo, K., Ukena, C., Sliwa, K., Schmieder, R.E., Sleight, P. and Yusuf, S. 2015. Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies. Journal of Internal Medicine, 278: 303-312.
    56. Bohm, M., Schumacher, H., Schmieder, R.E., Mann, J.F.E., Teo, K., Lonn, E., Sleight, P., Mancia, G., Linz, D., Mahfoud, F., Ukena, C., Sliwa, K., Bakris, G. and Yusuf, S. 2015. Resting heart rate is associated with renal diseaseoutcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies. Journal of Internal Medicine, 278: 38-49.
    57. Bohm, M., Schumacher, H., Leong, D., Mancia, G., Unger, T., Schmieder, R., Custodis, F.F., Diener, H., Laufs, U., Lonn, E.M. and Sliwa, K. 2015. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk. Hypertension, 65: 651-661.
    58. Botha-Scheepers, S. and Sarembock, B.D. 2015. Infections in the management of rheumatic diseases: an update. SAMJ South African Medical Journal, 105(12): 1076(3pp).
    59. Bowness, R., Boeree, M.J., Aarnoutse, R., Dawson, R., Diacon, A., Mangu, C.D., Heinrich, N., Ntinginya, E.N., Kohlenberg, A., Mtafya, B., Phillips, P.P.J., Rachow, A., Plemper van Balen, G. and Gillespie, S.H. 2015. The relationship between mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations. Journal of Antimicrobial Chemotherapy, 70: 448-455.
    60. Boyd, M.A., Moore, C.L., Molina, J.-M., Wood, R., Madero, J., Wolff, M., Ruxrungtham, K., Losso, M., Renjifo, B., Teppler, H. and Kelleher, A. 2015. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis. Lancet HIV, 2: e42-e51.
    61. Boyles, T.H. and Wasserman, S. 2015. Diagnosis of bacterial infection. SAMJ South African Medical Journal, 105(5): 419-421.
    62. Boyles, T.H., Davis, K., Crede, T., Malan, J., Mendelson, M. and Lesosky, M. 2015. Blood cultures taken from patients attending emergency departments in South Africa are an important antibiotic stewardship tool, which directly influences patient management. BMC Infectious Diseases, 15: 410(7pp).
    63. Boyles, T.H. 2015. Ebola: personal view from the field Sierra Leone. SAMJ South African Medical Journal, 105(12): 1008-1009.
    64. Boyles, T.H. 2015. Ceftolozane-tazobactam versus levofloxacin in urinary tract infection. Lancet, 386(10000): 1241
    65. Boyles, T.H., Hughes, J., Meintjes, G., Burton, R., Cox, V. and Mendelson, M. 2015. False-positive Xpert MTB/RIF assays and previous treatment. International Journal of Tuberculosis and Lung Disease, 19(4): 495-496.
    66. Boyles, T.H. 2015. Priorities in Ebola researcha view from the field. Lancet, 385(9962): 23.
    67. Brink, A.J., Cotton, M., Feldman, C., Finlayson, H., Friedman, R., Green, R., Hendson, W., Hockman, M.H., Maartens, G., Madhi, S.A., Reubenson, G., Silverbauer, E.J. and Zietsman, I.L. 2015. Updated recommendations for the management of upper respiratory tract infections in South Africa. SAMJ South African Medical Journal, 105(5): 345-352.
    68. Brouwer, E.D., Watkins, D.A., Olson, Z.D., Goett, J., Nugent, R.A. and Levin, C. 2015. Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review. BMC Public Health, 15: 1183(17pp).
    69. Brulhart-Meynet, M., Braunersreuther, V., Brinck, J., Montecucco, F., Prost, J., Thomas, A., Galan, K., Pelli, G., Pedretti, S., Vuilleumier, N., Mach, F., Lecour, S., James, R.W. and Frias, M.A. 2015. Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury. PLoS One, 10(3): e0119664(16pp).
    70. Buhl, R., Maltais, F., Abrahams, R., Bjermer, L., Derom, E., Ferguson, G.T., Flezar, M., Hebert, J., McGarvey, L., Pizzichini, E., Reid, J., Veale, A., Gronke, L., Hamilton, A., Korducki, L., Tetzlaff, K., Waitere-Wijker, S., Watz, H. and Bateman, E.D. 2015. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4). European Respiratory Journal, 45: 969-979.
    71. Burton, R. 2015. Ebola: experiences from the field Liberia. SAMJ South African Medical Journal, 105(12): 1006-1008.
    72. Cabrera, D.G., Douelle, F., Le Manach, C., Han, Z., Paquet, T., Taylor, D., Njoroge, M., Lawrence, N., Wiesner, L., Waterson, D., Witty, M.J., Wittlin, S., Street, L.J. and Chibale, K. 2015. Structure-activity relationship studies of orally active antimalarial 2,4-diamino-thienopyrimidines. Journal of Medicinal Chemistry, 58: 7572-7579.
    73. Caleyachetty, R., Echouffo-Tcheugui, J.B., Tait, C.A., Schilsky, S., Forrester, T.E. and Kengne, A.P. 2015. Prevalence of behavioural risk factors for cardiovascular disease in adolescents in low-income and middle-income countries: an individual participant data meta-analysis. Lancet Diabetes & Endocrinology, 3: 535-544.
    74. Calitz, C., Gous, C., Viljoen, J., Steenekamp, J., Wiesner, L., Abay, E. and Hamman, J. 2015. Herb-drug pharmacokinetic interactions: transport and metabolism of indinavir in the presence of selected herbal products. Molecules, 20: 22113-22127.
    75. Calligaro, G.L., Theron, G., Khalfey, H., Peter, J., Meldau, R., Matinyenya, B., Davids, M., Smith, L., Pooran, A., Lesosky, M., Esmail, A., Miller, M., Piercy, J.L., Michell, W.L., Dawson, R., Raine, R.I., Joubert, I. and Dheda, K. 2015. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial. Lancet Respiratory Medicine, 3: 621-630.
    76. Calligaro, G.L. and Gray, D. 2015. Lung function abnormalities in HIV-infected adults and children. Respirology, 20: 24-32.
    77. Camara, A., Balde, N.M., Sobngwi-Tambekou, J., Kengne, A.P., Diallo, M.M., Tchatchoua, A.P.K., Kake, A., Sylvie, N., Balkau, B., Bonnet, F. and Sobngwi, E. 2015. Poor glycemic control in type 2 diabetes in the South of the Sahara: the issue of limited access to an HbA1c test. Diabetes Research and Clinical Practice, 108: 187-192.
    78. Campbell, M.M., Susser, E., de Vries, J., Baldinger, A., Sibeko, G., Mndini, M.M., Mqulwana, S.G., Ntola, O.A., Ramesar, R.S. and Stein, D.J. 2015. Exploring researchers experiences of working with a researcher-driven, population-specific community advisory board in a South African schizophrenia genomics study. BMC Medical Ethics, 16: 45(9pp).
    79. Cannon, C.P., Cariou, B., Blom, D., McKenney, J.M., Lorenzato, C., Pordy, R., Chaudhari, U. and Colhoun, H.M. 2015. Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial. European Heart Journal, 36: 1186-1194.
    80. Castro, M., Zangrilli, J., Wechsler, M., Bateman, E.D., Brusselle, G.G., Bardin, P., Murphy, K., Maspero, J.F., O'Brien, C. and Korn, S. 2015. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: Results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respiratory Medicine, 3: 355-366.
    81. Celum, C., Delany-Moretlwe, S., McConnell, M., Van Rooyen, H., Bekker, L., Kurth, A., Bukusi, E.A., Desmond, C., Morton, J. and Baeten, J. 2015. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. Journal of the International AIDS Society, 18(3): 20227(10pp).
    82. Chervinsky, P., Meltzer, E.O., Busse, W., Ohta, K., Bardin, P., Bredenbroker, D. and Bateman, E.D. 2015. Roflumilast for asthma: safety findings from a pooled analysis of ten clinical studies. Pulmonary Pharmacology & Therapeutics, 35: S28-S34.
    83. Chigutsa, E., Pasipanodya, J.G., Visser, M.M.E., van Helden, P., Smith, P.J., Sirgel, F.A., Gumbo, T. and McIlleron, H. 2015. Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis. Antimicrobial Agents and Chemotherapy, 59(1): 38-45.
    84. Chin, A. and Phiri, T. 2015. An anteroseptal accessory pathway in a patient with Dextrocardia and Situs Inversus. Journal of Cardiovascular Electrophysiology, 26(6): 692-693.
    85. Chin, A. 2015. Management of rheumatic atrial fibrillation. SA Heart, 12: 152-155.
    86. Chirouze, C., Alla, F., Fowler Jr, V.G., Sexton, D.J., Corey, G.R., Chu, V.H., Wang, A., Erpelding, M.L., Durante-Mangoni, E.M., Fernndez-Hidalgo, N., Giannitsioti, E., Hannan, M.M., Lejko-Zupanc, T., Miro, J., Muoz, P., Murdoch, D.R., Tattevin, P., Tribouilloy, C., Hoen, B., Commerford, P.J., Commerford, A., Deetlefs, E., Hansa, C., Ntsekhe, M. and ICE Prospective Investigators, N./.A. 2015. Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: analysis in the international collaboration of endocarditisprospective cohort study. Clinical Infectious Diseases, 60(5): 741-749.
    87. Chopra, R., De Kock, C., Smith, P., Chibale, K. and Singh, K. 2015. Ferrocene-pyrimidine conjugates: synthesis, electrochemistry, physicochemical properties and antiplasmodial activities. European Journal of Medicinal Chemistry, 100: 1-9.
    88. Chughlay, M.F., Blockman, M. and Cohen, K. 2015. A clinical approach to drug-induced liver injury. Current Allergy & Clinical Immunology, 28(4): 252-256.
    89. Ciaranello, A.L., Myers, L., Kelly, K., Christensen, S., Daskilewicz, K., Doherty, K., Bekker, L., Hou, T., Wood, R., Francke, J.A., Wools-Kaloustian, K., Freedberg, K.A. and Walensky, R.P. 2015. Point-of-Care CD4 testing to inform selection of antiretroviral medications in South African antenatal clinics: a cost-effectiveness analysis. PLoS One, 10(3): e0117751(19pp).
    90. Cohn, J., Bekker, L., Bygrave, H. and Calmy, A. 2015. Hit me with your best shot: dolutegravir - a space in the next WHO guidelines? AIDS, 29: 2067-2070.
    91. Combrinck, J.M., Fong, K.Y., Gibhard, L., Smith, P.J., Wright, D.W. and Egan, T.J. 2015. Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials. Malaria Journal, 14(253): 1-14.
    92. Commerford, P.J., Commerford, A., Deetlefs, E., Hansa, C. and Ntsekhe, M. 2015. Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrobial Agents and Chemotherapy, 59: 2365-2373.
    93. Cornell, M., Johnson, L.F., Schomaker, M., Tanser, F., Maskew, M., Wood, R., Prozesky, H., Giddy, J., Stinson, K., Egger, M., Boulle, A.M. and Myer, L. 2015. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. Lancet HIV, 2: e368-e375.
    94. Coussens, A., Wilkinson, R.J. and Martineau, A. 2015. Phenylbutyrate is bacteriostatic against Mycobacterium tuberculosis and regulates the macrophage response to infection, synergistically with 25-Hydroxy-Vitamin D. PLOS Pathogens, 11(7): e1005007(23pp).
    95. Cox, V., De Azevedo, V., Stinson, K., Wilkinson, L., Rangaka, M. and Boyles, T.H. 2015. Diagnostic accuracy of tuberculin skin test self-reading by HIV patients in a low-resource setting. International Journal of Tuberculosis and Lung Disease, 19(11): 1300-1304.
    96. Dambuza, N., Smith, P., Evans, A.C., Norman, J.J., Taylor, D., Andayi, A.W., Egan, T.J., Chibale, K. and Wiesner, L. 2015. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model. Malaria Journal, 14: 505(8pp).
    97. Danieli, P., Malpasso, G., Ciuffreda, M.C., Cervio, E., Calvillo, L., Copes, F., Pisano, F., Mura, M., Kleijn, K., De Boer, R.A., Viarengo, G., Rosti, V., Spinillo, A., Roccio, M. and Gnecchi, M. 2015. Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis. Stem Cells Translational Medicine, 4: 1-11.
    98. Daniels, J., Khogali, M., Mohr, E., Cox, V., Moyo, S., Edginton, M., Gudmund Hinderaker, S., Meintjes, G., Hughes, J., De Azevedo, V., Van Cutsem, G. and Cox, H. 2015. Time to ART initiation among patients treated for rifampicin-resistant tuberculosis in Khayelitsha, South Africa: impact on mortality and treatment success. PLoS One, 10(11): e0142873(15pp).
    99. Dave, J.A., Cohen, K., Micklesfield, L.K., Maartens, G. and Levitt, N. 2015. Antiretrovira therapy, especially efavirenz, is associated with low bone mineral density in HIV-infected South Africans. PLoS One, 10(12): e0144286(9pp).
    100. Dave, J.A., Klisiewicz, A., Bayat, Z., Mohamed, N., Stevens, Z., Mollentze, W. and Kinvig, T. 2015. SEMDSA/ACE-SA guideline for the management of hypothyroidism in adults. Journal of Endocrinology, Metabolism and Diabetes of South Africa (JEMDSA), 20(2): 18-26.
    101. Davids, M., Dheda, K., Pai, N.P., Cogill, D., Pai, M. and Engel, N. 2015. A survey on use of rapid tests and Tuberculosis diagnostic practices by primary health care providers in South Africa: implications for the development of new point-of-care tests. PLoS One, 10(10): e0141453(14pp).
    102. Davies, M., Ford, N., Rabie, H., Fatti, G., Stinson, K., Giddy, J., Tanser, F., Technau, K.-G., Sawry, S., Eley, B.S., Wood, R., Mofenson, L., Keiser, O. and Boulle, A.M. 2015. Reducing CD4 monitoring in children on antiretroviral therapy with virologic suppression. Pediatric Infectious Disease Journal, 34(12): 1361-1364.
    103. Dawson, R., Diacon, A., Everitt, D., Van Niekerk, C., Donald, P.R., Burger, D., Schall, R., Spigelman, M., Conradie, A., Eisenach, K., Venter, A., Ive, P., Page-Shipp, L., Variava, E., Reither, K., Ntinginya, E.N., Pym, A. and von Groote-Bidlingmaier, F. 2015. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet, 385: 1738-1747.
    104. Dawson, R., Narunsky, K., Carman, D., Gupte, N., Whitelaw, A., Efron, A., Barnes, G.L., Hoffman, J., Chaisson, R.E., McIlleron, H. and Dorman, S.E. 2015. Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease, 19(7): 780-786.
    105. de Jager, C.A., Joska, J., Hoffman, M., Borochowitz, K.E. and Combrinck, M.I. 2015. Dementia in rural South Africa: a pressing need for epidemiological studies. SAMJ South African Medical Journal, 105(3): 189-190.
    106. de Melo Soares, C., Feng, T., van der Westhuyzen, R., Gessner, R.K., Street, L.J., Morgans, G.L., Warner, D., Moosa, A., Naran, K., Lawrence, N., Boshoff, H.I., Barry 3rd, C.E., Harris, C.J., Gordon, R. and Chibale, K. 2015. Aminopyrazolo [1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: structure activity relationships and ADME characterization. Bioorganic & Medicinal Chemistry, 23: 7240-7250.
    107. de Visser, V., Sotgiu, G., Lange, C., Aabye, M.G., Bakker, M., Bartalesi, F., Brat, K., Chee, C.B.E., Dheda, K., Dominguez, J., Eyuboglu, F., Ghanen, M., Goletti, D., Dilektasli, A.G., Guglielmetti, L., Koh, W.-J., Latorre, I., Losi, M., Polanova, M., Ravn, P., Ringshausen, F.C., Rumetshofer, R., de Souza-Galvao, M.L., Thijsen, S., Bothamley, G.H. and Bossink, A. 2015. False-negative interferon- release assay results in active tuberculosis: a TBNET study. European Respiratory Journal, 45: 279-283.
    108. de Vries, J., Tindana, P., Littler, K., Ramsay, M., Rotim, C., Abayomi, A., Mulder, N.J. and Mayosi, B.M. 2015. The H3Africa policy framework: Negotiating fairness in genomics. Trends in Genetics, 31(3): 117-119.
    109. Decloedt, E.H., Rosenkranz, B., Maartens, G. and Joska, J. 2015. Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations. Clinical Pharmacokinetics, 54: 581-598.
    110. Decloedt, E.H., Van der Walt, J.-S., McIlleron, H., Wiesner, J.L. and Maartens, G. 2015. The pharmacokinetics of lopinavir/ritonavir when given with isoniazid in South African HIV-infected individuals. International Journal of Tuberculosis and Lung Disease, 19(10): 1194-1196.
    111. Denoeud-Ndam, L., Dicko, A., Baudin, E., Guindo, O., Grandesso, F., Sagara, I., Lasry, E., Palma, P.B., Parra, A.M.L., Stepniewka, K., Djimde, A.A., Barnes, K.I., Doumbo, O.K. and Etard, J.-F. 2015. A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study. BMC Infectious Diseases, 15: 228(11pp).
    112. Denti, P., Jeremiah, K., Chigutsa, E., Faurholt-Jepsen, D., Praygod, G., Range, N., Castel, S.A., Wiesner, J.L., Hagen, C.M., Christiansen, M., Changalucha, J., McIlleron, H., Friis, H. and Andersen, A.B. 2015. Pharmacokinetics of isoniazid, pyrazinamide, and ethambutol in newly diagnosed pulmonary TB patients in Tanzania. PLoS One, 10(10): e0141002(19pp).
    113. Desmond, A.C., Moodley, D., Conolly, C.A., Castel, S.A. and Coovadia, H. 2015. Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life. BMC Pediatrics, 15: 23(8pp).
    114. Dheda, K., Koegelenberg, C., Esmail, A., Irusen, E., Wechsler, M., Niven, R.M., Chung, K.F. and Bateman, E.D. 2015. Indications for the use of bronchial thermoplasty in severe asthma. SAMJ South African Medical Journal, 105(10): 808-809.
    115. Dheda, K., Koegelenberg, C., Esmail, A., Irusen, E.M., Wechsler, M., Niven, R., Bateman, E.D. and Chung, K.F. 2015. Recommendations for the use of bronchial thermoplasty in the management of severe asthma. SAMJ South African Medical Journal, 105(9): 726-732.
    116. Diacon, A., Dawson, R., Von Groote-Bidlingmaier, F., Symons, G.J., Venter, A., Donald, P.R., Van Niekerk, C., Everitt, D., Hutchings, J., Burger, D., Schall, R. and Mendel, C.M. 2015. Bactericidal activity of Pyrazinamide and Clofazimine alone and in combinations with Pretomanid and Bedaquiline. American Journal of Respiratory and Critical Care Medicine, 191(8): 943-953.
    117. Dokainish, H., Koon, T., Zhu, J., Roy, A., Al-Habib, K., Elsayed, A., Palileo, L., Jaramillo, P.L., Karaye, K., Yusoff, K., Orlandini, A., Sliwa, K., Mondo, C., Lanas, F., Dorairaj, P., Huffman, M., Badr, A., Elmaghawry, M., Damasceno, A., Belley-Cote, E., Harkness, K., Grinvalds, A., McKelvie, R. and Yusuf, S. 2015. Heart failure in low- and middle-income countries: background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF). American Heart Journal, 170: 627-634.
    118. Dooley, K.E., Denti, P., Martinson, N., Cohn, S., Mashabela, F., Hoffmann, J., Haas, D.W., Hull, J., Msandiwa, R., Castel, S.A., Wiesner, L., Chaisson, R. and McIlleron, H. 2015. Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection. Journal of Infectious Diseases, 211: 197-205.
    119. du Plessis, L.H., Govender, K., Denti, P. and Wiesner, J.L. 2015. In vivo efficacy and bioavailability of lumefantrine: evaluating the application of Pheroid technology. European Journal of Pharmaceutics and Biopharmaceutics, 97: 68-77.
    120. Dunbar, G., Hellenberg, D.A. and Levitt, N. 2015. Diabetes mellitus and non-traumatic lower extremity amputations in four public sector hospitals in Cape Town, South Africa, during 2009 and 2010. SAMJ South African Medical Journal, 105(12): 1053-1056.
    121. Durao, S., Ajumobi, O., Kredo, T., Naude, C.E., Levitt, N., Steyn, K., Bradshaw, D. and Young, T. 2015. Evidence insufficient to confirm the value of population screening for diabetes and hypertension in low- and middle-income settings. SAMJ South African Medical Journal, 105(2): 98-102.
    122. Dzudie, A., Ojji, D., Anisiuba, B.C., Abdou, S., Cornick, R.V., Damasceno, A., Kane, A., Mocumbi, A.O., Mohamed, A., Nel, G., Ogola, E., Onwubere, B.J.C., Otieno, H., Rayner, B.L., Schutte, A., Ali, I., Twagirumukiza, M., Poulter, N. and Mayosi, B.M. 2015. Development of the roadmap and guidelines for the prevention and management of high blood pressure in Africa: proceedings of the PASCAR hypertension task force meeting: Nairobi, Kenya, 27 October 2014. Cardiovascular Journal of Africa, 26(2): 82-85.
    123. Ekengard, E., Glans, L., Cassells, I., Fogeron, T., Govender, P., Stringer, T., Chellan, P., Lisensky, G.C., Hersh, W.H., Doverbratt, I., Lidin, S., De Kock, C., Smith, P.J., Smith, G.S. and Nordlander, E. 2015. Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands. Dalton Transactions, 44: 19314-19329.
    124. Emanuel, S. and Hawarden, D. 2015. Cows milk protein allergy. Current Allergy & Clinical Immunology, 28(3): 206-209.
    125. Emanuel, S. and Hawarden, D. 2015. Bee sting allergy and immunotherapy. Current Allergy & Clinical Immunology, 28(2): 128-131.
    126. Engel, M.E., Haileamlak, A., Zuhlke, L., Lemmer, C.E., Nkepu, S.A., Van De Wall, M., Daniel, W., Shung King, M. and Mayosi, B.M. 2015. Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia. Heart, 101: 1389-1394.
    127. Engel, N., Davids, M., Blankvoort, N., Pai, N.P., Dheda, K. and Pai, M. 2015. Compounding diagnostic delays: a qualitative study of point-of-care testing in South Africa. Tropical Medicine & International Health, 20(4): 493-500.
    128. Ertekin, E., Moosa, S., Roos-Hesselink, J.W. and Sliwa, K. 2015. Two cases of cardiac sarcoidosis in pregnant women with supraventricular arrhythmia. Cardiovascular Journal of Africa, 26(2): 96-100.
    129. Essop, M.R., Galie, N., Badesch, D.B., Lalloo, U., Mahomed, A.G., Naidoo, D.P., Ntsekhe, M. and Williams, P.G. 2015. Management of pulmonary hypertension. SAMJ South African Medical Journal, 105(6): 437-439.
    130. Essouma, M., Noubiap, J.J., Bigna, J.J., Nansseu, J.R., Jingi, A.M., Aminde, L. and Zafack, J. 2015. Hypertension prevalence, incidence and risk factors among children and adolescents in Africa: a systematic review and meta-analysis protocol. BMJ Open, 5: e008472(5pp).
    131. Essouma, M. and Noubiap, J.J. 2015. Is air pollution a risk factor for rheumatoid arthritis? Journal of Inflammation-London, 12: 48(7pp).
    132. Everett-Murphy, K., de Villiers, A., Ketterer, E. and Steyn, K. 2015. Using formative research to develop a nutritioneducation resource aimed at assisting low-incomehouseholds in South Africa adopt a healthier diet. Health Education Research, 30(6): 882-896.
    133. Ezzati, M., Obermeyer, Z., Tzoulaki, L., Mayosi, B.M., Elliott, P. and Leon, D. 2015. Contributions of risk factors and medical care to cardiovascular mortality trends. Nature Reviews Cardiology, 12: 508-530.
  • F - J

    1. Fick, L. 2015. Epoxy resin and illness in the workplace. Current Allergy & Clinical Immunology, 28(3): 196-204.
    2. Flood, D., Wallace, M., Racow, K., Kublin, J. and Bekker, L. 2015. Attracting, equipping and retaining young medical doctors in HIV vaccine science in South Africa. Southern African Journal of HIV medicine, 16(1): 364(6pp).
    3. Foil, D.A., Evans, K., Brahmandam, S., He, W., Brewster, P., Yu, S., Murphy, T., Cutlip, D., Dworkin, L.D., Jamerson, K., Henrich, W., Kalra, P.A., Tobe, S., Thomson, K., Holden, A. and Rayner, B.L. 2015. Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis. Journal of the American Society of Hypertension, 9(6): 443-452.
    4. Folb, N., Timmerman, V., Levitt, N., Steyn, K., Bachmann, M.O., Lund, C., Bateman, E.D., Lombard, C., Gaziano, T., Zwarenstein, M. and Fairall, L. 2015. Multimorbidity, control and treatment of noncommunicable diseases among primary healthcare attenders in the Western Cape, South Africa. SAMJ South African Medical Journal, 105(8): 642-647.
    5. Folb, N., Lund, C., Fairall, L., Timmerman, V., Levitt, N., Steyn, K. and Bachmann, M.O. 2015. Socioeconomic predictors and consequences of depression among primary care attenders with non-communicable diseases in the Western Cape, South Africa: cohort studywithin a randomised trial. BMC Public Health, 15: 1194(12pp).
    6. Ford, N., Shubber, Z., Meintjes, G., Grinsztejn, B., Eholie, S., Mills, E., Davies, M., Vitoria, m., Penazzato, M., Nsanzimana, S., Frigati, L., O'Brien, D. and Ellman, T. 2015. Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV, 2: e438-e444.
    7. Ford, N., Meintjes, G., Pozniak, A., Bygrave, H., Hill, A., Peter, T., Davies, M., Grinsztejn, B., Calmy, A., Kumarasamy, N., Phanuphak, P., deBeaudrap, P., Vitoria, m., Doherty, M., Stevens, W.S. and Siberry, G.K. 2015. The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infectious Diseases, 15: 241-247.
    8. Frantz, J., Bezuidenhout, J., Burch, V.C., Mthembu, S., Rowe, m., Tan, C., Van Wyk, J. and Van Heerden, B. 2015. The impact of a faculty development programme for health professions educators in sub-Saharan Africa: an archival study. BMC Medical Education, 15:28(8pp).
    9. Fredericks, P., Britz, M., Eastman, R.W., Carr, J. and Bateman, K.J. 2015. Listerial Brainstem encephalitis treatable, but easily missed. SAMJ South African Medical Journal, 105(1): 17-20.
    10. Freercks, R. and Ndamase, S. 2015. The utility of urine sulphosalicylic acid testing in the detection of non-albumin proteinuria. SAMJ South African Medical Journal, 105(2): 153.
    11. Gabriels, G.A., Lambert, M.I., Smith, P.J., Wiesner, J.L. and Hiss, D. 2015. Melamine contamination in nutritional supplements - is it an alarm bell for the general consumer, athletes, and weekend warriors? Nutrition Journal, 14: 69(7pp).
    12. Gandhi, M., Glidden, D.V., Liu, A., Anderson, P.L., Horng, H., Defechereux, P., Guanira, J.V., Grinsztejn, B., Chariyalertsak, S., Bekker, L. and Grant, R. 2015. Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: implications for pre-exposure prophylaxis adherence monitoring. Journal of Infectious Diseases, 212: 1402-1406.
    13. Gane, E., Kershenobich, D., Seguin-Devaux, C., Kristian, P., Aho, I., Dalgard, O., Shestakova, I., Nymadawa, P., Blach, S., Acharya, S., Sonderup, M. and Spearman, C. 2015. Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2. Journal of Viral Hepatitis, 22(1): 46-73.
    14. Garcia-Prats, A.J., Draper, H.R., Thee, S., Dooley, K.E., McIlleron, H., Seddon, J.A., Wiesner, L., Castel, S.A., Schaaf, H.S. and Hesseling, A.C. 2015. Pharmacokinetics and safety of ofloxacin in children with drug-resistant tuberculosis. Antimicrobial Agents and Chemotherapy, 59(10): 6073-6079.
    15. Gaziano, T., Abrahams-Gessel, S., Denman, C., Montano, C.M., Khanam, M.A., Puoane, T. and Levitt, N. 2015. An assessment of community health workers' ability to screen for cardiovascular disease risk with a simple, non-invasive risk assessment instrument in Bangladesh, Guatemala, Mexico, and South Africa: an observational study. The Lancet Global Health, 3: e556-e563.
    16. Gaziano, T., Abrahams-Gessel, S., Surka, S., Sy, S., Pandya, A., Denman, C., Mendoza, C., Puoane, T. and Levitt, N. 2015. Cardiovascular disease screening by community health workers can be cost-effective in low- resource countries. Health Affairs, 34(9): 1538-1545.
    17. Gaziano, T., Cho, S., Sy, S., Pandya, A., Levitt, N. and Steyn, K. 2015. Increasing prescription length could cut cardiovascular disease burden and produce savings in South Africa. Health Affairs, 34(9): 1578-1585.
    18. Gcelu, A. and Kalla, A.A. 2015. Musculoskeletal disorders disease burden and challenges in the developing world. SAMJ South African Medical Journal, 105(12): 1070-1071.
    19. Geng, E.H., Neilands, T.B., Thiebaut, R., Bwana, M.B., Nash, D., Moore, R.J., Wood, R., Zannou, M.D., Althoff, K.N., Lim, P.L., Nachega, J., Easterbrook, P.J., Kambungu, A., Little, F., Nakigozi, G., Nakanjako, D., Kiggundu, V., LI, P.C.K., Bangsberg, D.R., Fox, M.P., Prozesky, H., Hunt, P.W., Davies, M., Reynolds, S.J., Egger, M., Yiannoutsos, C., Vittinghoff, E.V., Deeks, S.G. and Martin, J.N. 2015. CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. International Journal of Epidemiology, 44(1): 251-263.
    20. Getahun, H., Matteelli, A., Abubakar, I., Abdel Aziz, M., Baddeley, A., Barreira, D., Den Boon, S., Gutierrez, S.M.B., Bruchfeld, J., Burhan, E., Cavalcante, S.C., Cedillos, R., Chaisson, R., Chee, C.B.E., Chesire, L., Corbett, E.L., Dara, M., Denholm, J., de Vries, G., Falzon, D., Ford, N., Gale-Rowe, M., Gilpin, C., Girardi, E., Go, U.-Y., Govindasamy, D., Grant, A., Grzemska, M., Harris, R., Horsburgh Jr, C.R., Ismayilov, A., Jaramillo, E., Kik, S.K., Kranzer, K., Lienhardt, C., LoBue, P., Lnnroth, K., Marks, G., Menzies, D., Migliori, G.B., Mosca, D., Mukadi, Y.-D., Mwinga, A., Nelson, L., Nishikiori, N., Oordt-Speets, A., Rangaka, M.X., Reis, A., Rotz, L., Sandgren, A., Schepis, M.S., Schnemann, H.J., Sharm, S., Sotgiu, G., Stagg, R., Sterling, T.R., Tayeb, T., Uplekar, M., van der Werf, M., Van develde, W., van Kesse, F., Van'T Hoog, A., Varma, J.K., Vezhnina, N., Voniatis, C., Vonk Noordegraaf-Schouten, M., Weil, D., Weyer, K., Wilkinson, R.J., Yoshiyama, T., Zellweger, J.P. and Raviglione, M. 2015. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respiratory Journal, 46: 1563-1576.
    21. Gewitz, M.H., Baltimore, B.S., Tani, L.Y., Sable, C.A., Shulman, S.T., Carapetis, J., Remenyi, B., Taubert, K., Bolger, A.F., Beerman, L., Mayosi, B.M., Beaton, A., Pandian, N.G. and Kaplan, E.L. 2015. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography a scientific statement from the American Heart Association. Circulation, 131: 1806-1818.
    22. Goedecke, J.H., Keswell, D., Weinreich, C., Fan, J., Hauksson, J.H., Victor, H.S., Utzschneider, K.M., Levitt, N., Lambert, E.V., Kahn, S.E. and Olsson, T. 2015. Ethnic differences in hepatic and systemic insulin sensitivity and their associated determinants in obese black and white South African women. Diabetologia, 58: 2647–2652.
    23. Goedecke, J.H., Chorell, E., Livingstone, D.E.W., Stimson, R.H., Hayes, P., Adams, K.G., Dave, J.A., Victor, H.S., Levitt, N., Kahn, S.E., Seckl, J., Walker, B.R. and Olsson, T. 2015. Glucocorticoid receptor gene expression in adipose tissue and associated metabolic risk in black and white South African women. International Journal of Obesity, 39(2): 303-311.
    24. Coussens, A., Naude, C.E., Goliath, R.T., Chaplin, G., Wilkinson, R.J. and Jablonski, N. 2015. High-dose vitamin D3reduces deficiency caused by low UVB exposure and limits HIV-1 replication in urban Southern Africans. Proceedings of the National Academy of Sciences of the United States of America, 112(26): 8052-8057.
    25. Govender, K., Du Plessis, L., Gibhard, L. and Wiesner, L. 2015. Development and validation of a LC-MS/MS method for the quantitation of lumefantrine in mouse whole blood and plasma. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 985: 6-13.
    26. Govender, M., Aldous, C., Ferndale, L., Thomson, S.R. and Clarke, D.L. 2015. Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective. SAMJ South African Medical Journal, 105(10): 858-861.
    27. Grimsrud, A.T., Sharp, J., Kalombo, C., Bekker, L. and Myer, L. 2015. Implementation of community-based adherence clubs for stable antiretroviral therapy patients in Cape Town, South Africa. Journal of the International AIDS Society, 18: 19984(8pp).
    28. Gumbo, T., Pasipanodya, J.G., Nuermberger, E., Romero, K. and Hanna, D. 2015. Correlations between the hollow fiber model of Tuberculosis and therapeutic events in Tuberculosis patients: learn and confirm. Clinical Infectious Diseases, 61(Suppl 1): S18-S24.
    29. Gumbo, T., Pasipanodya, J.G., Romero, K., Hanna, D. and Nuermberger, E. 2015. Forecasting accuracy of the hollow fiber model of Tuberculosis for clinical therapeutic outcomes. Clinical Infectious Diseases, 61(Suppl 1): S25-S31.
    30. Gumbo, T., Lenaerts, A.J., Hanna, D., Romero, K. and Nuermberger, E. 2015. Nonclinical models for antituberculosis drug development: a landscape analysis. Journal of Infectious Diseases, 211(Suppl 3): S83-S95.
    31. Gumbo, T., Angulo-Barturen, I. and Ferrer-Bazaga, S. 2015. Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia. Journal of Infectious Diseases, 211(3): S96-S106.
    32. Gupta, R.K., Lucas, S., Fielding, K.L. and Lawn, S.D. 2015. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS, 29: 1987-2002.
    33. Hall, I.P., Fowler, A.V., Gupta, A., Tetzlaff, K., Nivens, M.C., Sarno, M., Finnigan, H.A., Bateman, E.D. and Sutherland, E.R. 2015. Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. Pulmonary Pharmacology & Therapeutics, 32: 37-44.
    34. Halle, M.P., Takongue, C., Kengne, A.P., Kaze, F.K. and Ngu, K.B. 2015. Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon. BMC Nephrology, 16: 59 (8pp).
    35. Harries, A.D., Lawn, S.D., Suthar, A.B. and Granich, R. 2015. Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation. Lancet Infectious Diseases, 15: 1492-1496.
    36. Hatzakis, A., Chulanov, V., Gadano, A.C., Bergin, C., Ben-Ari, Z., Mossong, J., Schreter, I., Baatarkhuu, O., Acharya, S., Aho, I., Anand, C., Andersson, M.I., Arendt, V., Arkkila, P., Barclay, K., Bessone, F., Blach, S., Blokhina, N., Brunton, C.R., Chaudhari, G., Cisneros, L., Croes, E.A., Dahgwahdorj, Y.A., Dalgard, O., Daruich, J.R., Dashdorj, N.R., Davaadorj, D., De Knegt, R.J., De Vree, M., Estes, C., Flisiak, R., Gane, E., Gower, E., Halota, W., Henderson, C., Hoffmann, P., Hornell, J., Houlihan, D., Hrusovsky, S., Jarcuska, P., Kershenobich, D., Kostrzewska, K., Kristian, P., Leshno, M., Lurie, Y., Mahomed, A., Mamonova, N., Mendez-Sanchez, N., Norris, S., Nurmukhamet, E., Nymadawa, P., Oltman, M., Oyunbileg, J., Oyunsuren, T.S., Papatheodorid, G., Pimenov, N., Prabdial-Sing, N., Prins, M., Radke, S., Rakhmanova, A., Razavi-Shearer, K., Reesink, H.W., Ridruejo, E., Safadi, R., Sagalova, O., Sanchez Avila, A., Sanduijav, R., Saraswat, V., Seguin-Devaux, C., Shah, R.S., Shestakova, I., Shevaldin, A., Shibolet, O., Silva, M.O., Sokolov, S., Sonderup, M., Souliotis, K. and Spearman, C. 2015. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. Journal of Viral Hepatitis, 22(Supplement 1): 26-45.
    37. Heinrich, N., Dawson, R., Du Bois, J., Narunsky, K., Horwith, G., Phipps, A., Nacy, C., Aarnoutse, R., Boeree, M.J., Gillespie, S., Venter, A., Henne, S., Rachow, A., Phillips, P.P.J., Hoelscher, M. and Diacon, A. 2015. Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients. Journal of Antimicrobial Chemotherapy, 70: 1558-1566.
    38. Henry, M., Wolf, P., Ross, I.L. and Thomas, K. 2015. Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison's disease. Physiology & Behavior, 151: 379-385.
    39. Hermans, S., Horsburgh Jr, C.R. and Wood, R. 2015. A century of tuberculosis epidemiology in the northern and southern hemisphere: the differential impact of control interventions. PLoS One, 10(8): e0135179(13pp).
    40. Hermans, S., Boulle, A.M., Caldwell, J., Pienaar, D. and Wood, R. 2015. Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis. Journal of the International AIDS Society, 18: 20240(7pp).
    41. Hess, A.T., Bissell, M.M., Ntusi, N., Lewis, A.J.M., Tunnicliffe, E.M., Greiser, A., Stalder, A.F., Francis, J.M., Myerson, S.G., Neubauer, S. and Robson, M.D. 2015. Aortic 4D flow: quantification of signal-to-noise ratio as a function of field strength and contrast enhancement for 1.5T, 3T, and 7T. Magnetic Resonance in Medicine, 73: 1864-1871.
    42. Hesseling, A.C., Jaspan, H.B., Black, G.F., Nene, N. and Walzl, G. 2015. Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination. International Journal of Tuberculosis and Lung Disease, 19(4): 454-462.
    43. Hlela, C., Lunjani, N., Gumedze, F.N., Kakande, J. and Khumalo, N. 2015. Affordable moisturisers are effective in atopic eczema: a randomised controlled trial. SAMJ South African Medical Journal, 105(9): 780-784.
    44. Hodkinson, B. and Makda, M.A. 2015. Evidence-based treatment of systemic lupus erythematosus and its complications. SAMJ South African Medical Journal, 105(12): 1075(5pp).
    45. Hofman, K.J., Cook, C.D. and Levitt, N. 2015. Preventing diabetic blindness: a priority for South Africa. SAMJ South African Medical Journal, 104(10): 661-662.
    46. Hogeweg, L., Sanchez, C.I., Maduskar, P., Philipsen, R.H.H.M., Story, A., Dawson, R., Theron, G., Dheda, K., Peters-Bax, L. and van Ginneken, B. 2015. Automatic detection of tuberculosis in chest radiographs using a combination of textural, focal, and shape abnormality analysis. IEEE Transactions on Medical Imaging, 34(12): 2429-2442.
    47. Hohlfeld, J.M., Furtwaengler, A., Konen-Bergmann, M., Wallenstein, G., Walter, B. and Bateman, E.D. 2015. Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials. International Journal of Clinical Practice, 69(1): 72-80.
    48. Hughes, J., Isaakidis, P., Andries, A., Mansoor, H., Cox, V., Meintjes, G. and Cox, H. 2015. Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients. European Respiratory Journal, 46: 271-273.
    49. Igwesi-Chidobe, C.N., Godfrey, E.L. and Kengne, A.P. 2015. Effective components of exercise and physical activity-related behaviour-change interventions for chronic non-communicable diseases in Africa: protocol for a systematic mixed studies review with meta-analysis. BMJ Open, 5: e008036(18pp).
    50. Issarow, C., Mulder, N.J. and Wood, R. 2015. Modelling the risk of airborne infectious disease using exhaled air. Journal of Theoretical Biology, 372: 100-106.
    51. Ives-Deliperi, V. and Butler, J.T. 2015. Functional mapping in pediatric epilepsy surgical candidates: functional magnetic resonance imaging under sedation with chloral hydrate. Pediatric Neurology, 53: 478-484.
    52. Jabar, A., Barth, D., Matzopoulos, R. and Engel, M.E. 2015. Is the introduction of violence and injury observatories associated with a reduction of violence in adult populations? Rationale and protocol for a systematic review. BMJ Open, 5: e007073(5pp).
    53. Jacobs, A. and Wilkinson, R.J. 2015. Humoral immunity in tuberculosis. European Journal of Immunology, 45: 647-649.
    54. Jacobs, L., De Kock, C., De Villiers, K., Smith, P.J., Smith, V., van Otterlo, W.A.L. and Blackie, A.L. 2015. Design, synthesis, and evaluation of novel Ferroquine and Phenylequine analogues as potential antiplasmodial agents. ChemMedChem, 10: 2099-2110.
    55. Jama, Z., Chin, A., Badri, M. and Mayosi, B.M. 2015. Performance of re-used pacemakers and implantable cardioverter defibrillators compared with new devices at Groote Schuur Hospital in Cape Town, South Africa. Cardiovascular Journal of Africa, 26(4): 181-187.
    56. James, K., Grace, L., Thomas, K. and Combrinck, M.I. 2015. Associations between CAMCOG-R subscale performance and formal education attainment in South African older adults. International Psychogeriatrics, 27(2): 251-260.
    57. James, M.F.M., Joubert, I., Michell, W.L., Nicol, A., Navsaria, P.H. and Gillespie, R.S. 2015. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for non-septic ICU patients: a rebuttal. Critical Care, 19: 444.
    58. Janssen, S., Wieten, R.W., Stolp, S., Cremers, A.L., Rossatanga, E.G., Klipstein-Grobusch, K., Belard, S. and Grobusch, M. 2015. Factors associated with retention to care in an HIV clinic in Gabon, central Africa. PLoS One, 10(10): e0140746(14pp).
    59. Janssen, S., Hermans, S., Knap, M., Moekotte, A., Rossatanga, E.G., Adegnika, A.A., Belard, S., Hanscheid, T. and Grobusch, M. 2015. Impact of anti-retroviral treatment and cotrimoxazole prophylaxis on helminth infections in HIV-infected patients in Lambarn, Gabon. Plos Neglected Tropical Diseases, 9(5): e0003769(13pp).
    60. Jarvis, J.N., Meintjes, G., Bicanic, T., Buffa, V., Hogan, L., Mo, S., Tomlinson, G.S., Kropf, P., Noursadeghi, M. and Harrison, T.S. 2015. Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis. PLoS Pathogens, 11(4): e1004754(17pp).
    61. Jobson, G., Struthers, H. and McIntyre, J.A. 2015. In the fell clutch of circumstance: HIV and men who have sex with men in Sub-Saharan Africa. Current HIV/AIDS Report, 12: 164-172.
    62. Johnson, L.F., Dorrington, R.E., Laubscher, R., Hoffmann, C.J., Wood, R., Fox, M.P., Cornell, M., Schomaker, M., Prozesky, H., Tanser, F., Davies, M. and Boulle, A.M. 2015. A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment. Journal of the International AIDS Society, 18: 20628(7pp).
    63. Johnson, L., Rehle, T., Jooste, S. and Bekker, L. 2015. Rates of HIV testing and diagnosis in South Africa: successes and challenges. AIDS, 29: 1401-1409.
    64. Jones, C.E., Hesseling, A.C., Tena-Coki, N., Scriba, T., Chegou, N.N., Kidd, M., Wilkinson, R.J. and Kampmann, B. 2015. The impact of HIV exposure and maternal mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Gurin vaccination. AIDS, 29: 155-165.
    65. Jones, E. and Rayner, B.L. 2015. Hypertension, end-stage renal disease and mesangiocapillary glomerulonephritis in methamphetamine users. SAMJ South African Medical Journal, 105(3): 199-201.
  • K - O

    1. Kakande, B. 2015. Clothing contact dermatitis. Current Allergy & Clinical Immunology, 28(1): 46-52.
    2. Kakande, B. and Lehloenya, R.J. 2015. Drug reactions associated with antituberculosis drugs. Current Allergy & Clinical Immunology, 28(4): 264-268.
    3. Kalula, S.Z., Ferreira, M., Swingler, G.H. and Badri, M. 2015. Ethnic differences in rates and causes of falls in an urban community-dwelling older population in South Africa. Journal of the American Geriatrics Society, 63(2): 403-404.
    4. Kalula, S.Z., Ferreira, M., Swingler, G., Badri, M. and Sayer, A.A. 2015. Prevalence of falls in an urban community-dwelling older population of Cape Town, South Africa. Journal of Nutrition Health & Aging, 19(10): 1024-1031.
    5. Kamali, A., Price, M.A., Lakhi, S., Karita, E., Inambao, M., Sanders, E.J., Anzala, O., Latka, M.H., Bekker, L., Kaleebu, P., Asiki, G., Ssetaala, A., Ruzagira, E., Allen, S., Farmer, P., Hunter, E., Mutua, G., Makkan, H., Tichacek, A., Brill, I.K., Fast, P., Stevens, G., Chetty, P., Amornkul, P.N. and Gilmour, J. 2015. Creating an African HIV clinical research and prevention trials network: HIV prevalence, incidence and transmission. PLoS One, 10(1): e0116100(19pp).
    6. Kamkuemah, M.N., Kaplan, R., Bekker, L., Little, F. and Myer, L. 2015. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a primary healthcare setting in South Africa. Tropical Medicine & International Health, 20(4): 518-526.
    7. Kastelein, J., Ginsberg, H.N., Langslet, G., Hovingh, G.K., Ceska, R., Dufour, R., Blom, D., Civeira, F., Krempf, M., Lorenzato, C., Zhao, J., Pordy, R., Baccara-Dinet, M.T., Gipe, D.A., Geiger, M.J. and Farnier, M. 2015. ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia. European Heart Journal, 36: 2996-3003.
    8. Katchanov, J., Blechschmidt, C., Nielsen, K., Branding, G., Arasteh, K., Tintelnot, K., Meintjes, G., Boulware, D.R. and Stocker, H. 2015. Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution. International Journal of Std & Aids, 26(12): 912-914.
    9. Kaur, G., Singh, K., Pavadai, E., Njoroge, M., Espinoza-Moraga, M., De Kock, C., Smith, P.J., Wittlin, S. and Chibale, K. 2015. Synthesis of fusidic acid bioisosteres as antiplasmodial agents and molecular docking studies in the binding site of elongation factor-G. MedChemComm, 6: 2023-2028.
    10. Kaur, H., Machado, M., De Kock, C., Smith, P.J., Chibale, K., Prudencio, M. and Singh, K. 2015. Primaquine-pyrimidine hybrids: synthesis and dual-stage antiplasmodial activity. European Journal of Medicinal Chemistry, 101: 266-273.
    11. Kaur, H., Balzarini, J., De Kock, C., Smith, P.J., Chibale, K. and Singh, K. 2015. Synthesis, antiplasmodial activity and mechanistic studies of pyrimidine-5-carbonitrile and quinoline hybrids. European Journal of Medicinal Chemistry, 101: 52-62.
    12. Kaze, F.F., Kengne, A.P., Mambap, A.T., Halle, M.P., Mbanya, D. and Ashuntantang, G. 2015. Anemia in patients on chronic hemodialysis in Cameroon: prevalence, characteristics and management in low resources setting. African Health Sciences, 15(1): 253-260.
    13. Kaze, F.F., Meto, D.T., Halle, M.P., Ngogang, J. and Kengne, A.P. 2015. Prevalence and determinants of chronic kidney disease in rural and urban Cameroonians: a cross-sectional study. BMC Nephrology, 16: 117(10pp).
    14. Kaze, F.F., Halle, M.P., Mopa, H.T., Ashuntantang, G., Fouda, H., Ngogang, J. and Kengne, A.P. 2015. Prevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study. BMC Nephrology, 16: 96(8pp).
    15. Kengne, A.P., Matzopoulos, R., Mason-Jones, A.J. and Sliwa, K. 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385: 117 -171.
    16. Kengne, A.P., Matzopoulos, R., Sliwa, K., Mayosi, B.M. and Stein, D.J. 2015. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386: 2287–2323.
    17. Kenyon, C. and Buyze, J. 2015. No association between gender inequality and peak HIV prevalence in developing countries - an ecological study. Aids Care, 27(2): 150-159.
    18. Kengne, A.P., Mason-Jones, A.J., Sliwa, K., Mayosi, B.M., Stein, D.J. and Matzopoulos, R. 2015. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386: 743–800.
    19. Kenyon, C. and Colebunders, R. 2015. Correlates of concurrency among young people in Carletonville, South Africa. SAHARA: Journal of Social Aspects of HIV/AIDS, 12(1): 51-58.
    20. Kenyon, C., Tsoumanis, A. and Schwartz, I.S. 2015. HIV prevalence correlates with high-risk sexual behavior in Ethiopia's regions. PLoS One, 10(10): e0140835(13pp)
    21. Kenyon, C., Osbak, K., Buyze, J. and Chico, M.R. 2015. The changing relationship between bacterial STIs and HIV prevalence in South Africa - an ecological study. International Journal of Std & Aids, 26(8): 556-564.
    22. Kenyon, C., Kirungi, W., Kaharuza, F., Buyze, J. and Bunnell, R. 2015. Who knows their partner's HIV status? results from a nationally representative survey in Uganda. Jaids-Journal of Acquired Immune Deficiency Syndromes, 69: 92-97.
    23. Kerkhoff, A., Wood, R., Cobelens, F., Gupta-Wright, A., Bekker, L. and Lawn, S.D. 2015. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Medicine, 13: 70(13pp).
    24. Kerpel-Fronius, S., Rosenkranz, B., Allen, E., Bass, R., Mainard, J.D., Dodoo, A., Dubois, D.J., Hela, M., Kern, S., Massud, J., Silva, H. and Whitty, J. 2015. Education and training for medicines development, regulation and clinical research in emerging countries. Frontiers in Pharmacology, 6: 80(8pp).
    25. Kerstjens, H.A.M., Casale, T.B., Bleecker, E.R., Meltzer, E.O., Pizzichini, E., Schmidt, O., Engel, M., Bour, L., Verkleij, C.B., Moroni-Zentgraf, P. and Bateman, E.D. 2015. Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials. Lancet Respiratory Medicine, 3: 367-376.
    26. Kew, M.C. 2015. Obesity as a cause of hepatocellular carcinoma. Annals Of Hepatology, 14(3): 299-303.
    27. Kingue, S., Ngoe, C.N., Menanga, P., Jingi, A.M., Noubiap, J.J., Fesuh, B., Nouedoui, C., Andze, G. and Muna, W.F.T. 2015. Prevalence and risk factors of hypertension in urban areas of Cameroon: a nationwide population-based cross-sectional study. Journal of Clinical Hypertension, 17(10): 819-824.
    28. Knight, L., Todd, G., Muloiwa, R., Matjila, M. and Lehloenya, R.J. 2015. Stevens Johnson Syndrome and toxic epidermal necrolysis: maternal and foetal outcomes in twenty- two consecutive pregnant HIV infected women. PLoS One, 10(8): e0135501(11pp).
    29. Koegelenberg, C., Theron, J., Bruwer, J.W., Allwood, B., Vorster, M.J., von Groote-Bidlingmaier, F. and Dheda, K. 2015. Endoscopic lung volume reduction in severe emphysema. SAMJ South African Medical Journal, 105(9): 721-723.
    30. Koegelenberg, C., Theron, J., Dheda, K., Bruwer, J.W., Allwood, B., Vorster, M., von Groote-Bidlingmaier, F., Slebos, D.-J., Shah, P. and Herth, F. 2015. Recommendations for the use of endoscopic lung volume reduction in South Africa: role in the treatment of emphysema. SAMJ South African Medical Journal, 105(10): 810-815.
    31. Koegelenberg, C.F.N., Slebos, D.-J., Shah, P.l., Theron, J., Dheda, K., Allwood, B. and Herth, F. 2015. Time for the global rollout of endoscopic lung volume reduction. Respiration, 90: 430-440.
    32. Koller, M., Fatti, G., Chi, B.H., Keiser, O., Hoffmann, C.J., Wood, R., Prozesky, H., Stinson, K., Giddy, J., Mutevedzi, P., Fox, M.P., Law, M., Boulle, A.M. and Egger, M. 2015. Risk charts to guide targeted HIV-1 viral load monitoring of ART: Development and validation in patients from resource-limited settings. Jaids-Journal of Acquired Immune Deficiency Syndromes, 70(3): e110-e119.
    33. Krige, J.E.J., Kotze, U.K., Setshedi, M., Nicol, A. and Navsaria, P.H. 2015. Prognostic factors, morbidity and mortality in pancreatic trauma: a critical appraisal of 432 consecutive patients treated at a Level 1 Trauma Centre. Injury-International Journal of the Care of the Injured, 46: 830-836.
    34. Kuate-Tegueu, C., Temfack, E., Ngankou, S., Doumbe, J., Djientcheu, V.P. and Kengne, A.P. 2015. Prevalence and determinants of diabetic polyneuropathy in a sub-Saharan African referral hospital. Journal of the Neurological Sciences, 355: 108-112.
    35. Kullin, B., Meggersee, R.L., D'Alton, J., Galvao, B., Rajabally, M.N., Whitelaw, A.C., Bamford, C., Reid, S.J. and Abratt, V.R. 2015. Prevalence of gastrointestinal pathogenic bacteria in patients with diarrhoea attending Groote Schuur Hospital, Cape Town, South Africa. SAMJ South African Medical Journal, 105(2): 121-125.
    36. Lado, M., Walker, N.F., Baker, P., Haroon, S., Brown, C.S., Youkee, D., Studd, N., Kessete, Q., Maini, R., Boyles, T.H., Hanciles, E., Wurie, A., Kamara, T.B., Johnson, O. and Leather, A.J.M. 2015. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infectious Diseases, 15: 1024-1033.
    37. Lai, R., Meintjes, G., Wilkinson, K., Graham, C.M., Marais, S., van Der Plas, H., Deffur, A., Schutz, C., Bloom, C., Munagala, I., Anguiano, E., Goliath, R.T., Maartens, G., Banchereau, J., Chaussabel, D., O'Garra, A. and Wilkinson, R.J. 2015. HIV-Tuberculosis-Associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling. Nature Communications, 6: 8451(11pp).
    38. Laing, G., Bruce, J., Skinner, D., Allorto, N., Aldous, C., Thomson, S.R. and Clarke, D. 2015. Using a hybrid electronic medical record system for the surveillance of adverse surgical events and human error in a developing world surgical service. World Journal of Surgery, 39: 70-79.
    39. Lamont, K., Nduhirabandi, F., Adam, T., Thomas, P., Opie, L.H. and Lecour, S. 2015. Role of melatonin, melatonin receptors and STAT3 in the cardioprotective effect of chronic and moderate consumption of red wine. Biochemical and Biophysical Research Communications, 465: 719-724.
    40. Lavatelli, F., Imperlini, E., Orr, S., Rognoni, P., Sarnataro, D., Palladini, G., Malpasso, G., Soriano, M.E., Di Fonzo, A., Valentini, V., Gnecchi, M., Perlini, S., Salvatore, F. and Merlini, G. 2015. Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis. Faseb Journal, 29: 4614-4628.
    41. Lawn, S.D. and Wilkinson, R.J. 2015. ART and prevention of HIV-associated Tuberculosis. Lancet HIV, 2: e221-e222.
    42. Lawn, S.D. 2015. Advances in diagnostic assays for tuberculosis. Cold Springs Harbor Perspectives in Medicine, 5(12): a017806(18pp).
    43. Lawn, S.D. and Nicol, M.P. 2015. Dead or Alive: can viability staining predict response to tuberculosis treatment. Clinical Infectious Diseases, 60(8): 1196-1198.
    44. Lawn, S.D., Nicol, M.P. and Corbett, E.L. 2015. Effect of empirical treatment on outcomes of clinical trials of diagnostics assays for tuberculosis. Lancet Infectious Diseases, 15: 17-18.
    45. Lawn, S.D., Kerkhoff, A., Nicol, M.P. and Meintjes, G. 2015. Underestimation of the true specificity of the urine Lipoarabinomannan point-of-care diagnostic assay for HIV-Associated Tuberculosis. JAIDS-Journal of Acquired Immune Deficiency Syndromes, 69(4): e144-e146.
    46. Lawn, S.D., Kerkhoff, A., Burton, R., Schutz, C., Van Wyk, G., Vogt, M.C., Pahlana, P., Nicol, M.P. and Meintjes, G. 2015. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa. BMC Medicine, 13: 192(13pp).
    47. Lee Pan, E.B. and Tucker, L.M. 2015. An approach to epilepsy. SAMJ South African Medical Journal, 105(8): 693(3pp).
    48. Lehloenya, R.J., Muloiwa, R., Dlamini, S.K., Gantsho, N., Todd, G. and Dheda, K. 2015. Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases. Journal of Antimicrobial Chemotherapy, 70: 2648-2651.
    49. Lekoubou, A., Nkoke, C., Dzudie, A. and Kengne, A.P. 2015. Stroke admission and case-fatality in an urban medical unit in sub-Saharan Africa: a fourteen year trend study from 1999 to 2012. Journal of the Neurological Sciences, 350: 24-32.
    50. Leon, N., Surender, R., Bobrow, K.L., Muller, J. and Farmer, A. 2015. Improving treatment adherence for blood pressure lowering via mobile phone SMS-messages in South Africa: a qualitative evaluation of the SMS-text adherence suppoRt (StAR) trial service organization, utilization, and delivery of care. BMC Family Practice, 16: 80(10pp).
    51. Levitt, N., Puoane, T., Denman, C., Abrahams-Gessel, S., Surka, S., Mendoza, C., Khanam, M.A., Sartaj, A. and Gaziano, T.A. 2015. Referral outcomes of individuals identified at high risk of cardiovascular disease by community health workers in Bangladesh, Guatemala, Mexico, and South Africa. Global Health Action, 8: 26318 (7pp).
    52. Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H.M., Okpechi, I.G., Zhao, M.-H., Lv, J., Garg, A.X., Knight, J., Rodgers, A., Gallagher, M., Kotwal, S., Cass, A. and Perkovic, V. 2015. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet, 385: 1975-1982.
    53. London, G., Mayosi, B.M. and Khati, M. 2015. Isolation and characterization of 2-F-RNA aptamers against whole HIV-1 subtype C envelope pseudovirus. Biochemical and Biophysical Research Communications, 456: 428-433.
    54. Lundgren, J., Babiker, A., Gordin, F., Emery, S., Grund, B., Sharma, S., Avihingsanon, A.-C., Cooper, D., Ftkenheuer, G., Llibre, J.M., Molina, J.-M., Munderi, P., Schechter, M. and Wood, R. 2015. Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine, 373: 795-807.
    55. Maarman, G., Blackhurst, D.M., Thienemann, F., Blauwet, L., Butrous, G., Davies, N.H., Sliwa, K. and Lecour, S. 2015. Melatonin as a preventive and curative therapy against pulmonary hypertension. Journal of Pineal Research, 59: 343-353.
    56. Maartens, G. and Meintjies, G. 2015. Lower-dose efavirenz: what is needed before implementation? Lancet, 15(7): 749-751.
    57. Malan, Z., Mash, B. and Murphy, K. 2015. A situational analysis of training for behaviour change counselling for primary care providers, South Africa. African Journal of Primary Health Care & Family Medicine, 7(1): 731(10pp).
    58. Malan, Z., Mash, B. and Everett-Murphy, K. 2015. Development of a training programme for primarycare providers to counsel patients with risky lifestyle behaviours in South Africa. African Journal of Primary Health Care & Family Medicine, 7(1): 819(8pp).
    59. Malan, Z., Mash, R. and Everett-Murphy, K. 2015. Qualitative evaluation of primary care providers experiences of a training programme to offer brief behaviour change counselling on risk factors for non-communicable diseases in South Africa. BMC Family Practice, 16: 101(10pp).
    60. Masconi, K., Matsha, T.E., Erasmus, R.T. and Kengne, A.P. 2015. Effects of different missing data imputation techniques on the performance of undiagnosed diabetes risk prediction models in a mixed-ancestry population of South Africa. PLoS One, 10(9): e0139210(9pp).
    61. Masconi, K., Matsha, T.E., Erasmus, R.T. and Kengne, A.P. 2015. Independent external validation and comparison of prevalent diabetes risk prediction models in a mixed-ancestry population of South Africa. Diabetology & Metabolic Syndrome, 7(1): 42(10pp).
    62. Mash, R., Kroukamp, R., Gaziano, T. and Levitt, N. 2015. Cost-effectiveness of a diabetes group education program delivered by health promoters with a guiding style in underserved communities in Cape Town, South Africa. Patient Education and Counseling, 98: 622-626.
    63. Matsha, T.E., Kengne, A.P., Masconi, K., Yako, Y.Y. and Erasmus, R.T. 2015. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans. BMC Genetics, 16: 69(9pp).
    64. Matthews, K., Deffur, A., Ntsekhe, M., Syed, F., Russell, J.B.W., Tibazarwa, K., Wolske, J., Brink, J.G., Mayosi, B.M., Wilkinson, R.J. and Wilkinson, K. 2015. A compartmentalized profibrotic immune response characterizes pericardial tuberculosis, irrespective of HIV-1 infection. American Journal of Respiratory and Critical Care Medicine, 192(12): 1518-1520.
    65. Mayosi, B.M., Stein, D.J., Kengne, A.P. and Sliwa, K. 2015. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386(9995): 743-800.
    66. Mayosi, B.M. 2015. Pericarditis-associated atrial fibrillation. BMJ Open, 101(18): 1439-1440.
    67. Mayosi, B.M. 2015. Towards host-directed therapies for tuberculosis. Nature Reviews Drug Discovery, 14(8): 511-512.
    68. Mayosi, B.M., Kengne, A.P. and Matzopoulos, R. 2015. Duplicate Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 19902013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386: 2287-2323.
    69. Mayosi, B.M. 2015. The first black doctors and their influence in South Africa. SAMJ South African Medical Journal, 105(8): 635-636.
    70. Mbanya, V.N., Hussain, A. and Kengne, A.P. 2015. Application and applicability of non-invasive risk models for predicting undiagnosed prevalent diabetes in Africa: a systematic literature search. Primary Care Diabetes, 9: 317-329.
    71. Mbanya, V.N., Kengne, A.P., Mbanya, J.C. and Akhtar, H. 2015. Body mass index, waist circumference, hip circumference, waist-hip-ratio and waist-height-ratio: which is the better discriminator of prevalent screen-detected diabetes in a Cameroonian population? Diabetes Research and Clinical Practice, 108: 23-30.
    72. Mbanya, V.N., Echouffo-Tcheugui, J.B., Akhtar, H., Mbanya, J.C. and Kengne, A.P. 2015. Obesity phenotypes in urban and rural Cameroonians: a cross-sectional study. Diabetology & Metabolic Syndrome, 7: 21(8pp).
    73. McIlleron, H., Abdel-Rahman, S., Dave, J.A., Blockman, M. and Owens, A. 2015. Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research. Journal of Infectious Diseases, 211(Suppl 3): S115-S125.
    74. Meintjes, G., Kerkhoff, A., Burton, R., Schutz, C., Boulle, A.M., Van Wyk, G., Blumental, L., Nicol, M.P. and Lawn, S.D. 2015. HIV-related medical admissions to a South African district hospital remain frequent despite effective antiretroviral therapy scale-up. Medicine, 94(50): e2269(10pp).
    75. Meintjes, G., Black, J., Conradie, F., Dlamini, S.K., Maartens, G., Manzini, T., Mathe, M., Moorhouse, M., Moosa, Y., Nash, J., Orrell, C., Venter, W.D.F. and Wilson, D. 2015. Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: update on when to initiate antiretroviral therapy. Southern African Journal of HIV Medicine, 16(1): 428(4pp).
    76. Meintjes, G., Dunn, L., Coetsee, M., Hislop, M., Leisegang, R., Regensberg, L. and Maartens, G. 2015. Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study. AIDS Research and Therapy, 12: 39(7pp).
    77. Melariri, P., Kalombo, L., Nkuna, P., Dube, A., Hayeshi, R., Ogutu, B., Gibhard, L., De Kock, C., Smith, P., Wiesner, L. and Swai, H. 2015. Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice. International Journal of Nanomedicine, 10: 1493-1503.
    78. Meltzer, E.O., Chervinsky, P., Busse, W., Ohta, K., Bardin, P., Bredenbroker, D. and Bateman, E.D. 2015. Roflumilast for asthma: efficacy findings in placebo-controlled studies. Pulmonary Pharmacology & Therapeutics, 35: S20-S27.
    79. Mendelson, M. 2015. Role of antibiotic stewardship in extending the age of modern medicine. SAMJ South African Medical Journal, 105(5): 414-418.
    80. Mendelson, M. 2015. Animal-associated exposure to rabies virus among travelers, 1997-2012. Emerging Infectious Diseases, 21(4): 569-577.
    81. Mercier, S., Kury, S., Salort-Campana, E., Magot, A., Agbim, U., Besnard, T., Bodak, N., Bou-Hanna, C., Breheret, F., Brunelle, P., Cailon, F., Chabrol, B., Cormier-Daire, V., David, A., Eymard, B., Faivre, L., Khumalo, N., Mayosi, B.M., Barbarot, S. and Bezieau, S. 2015. Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations. Orphanet Journal of Rare Diseases, 10: 135(16pp).
    82. Mfutso-Bengo, J., Manda-Taylor, L. and Masiye, F. 2015. Motivational factors for participation in biomedical research: evidence from a qualitative study of biomedical research participation in Blantyre District, Malawi. Journal of Empirical Research on Human Research Ethics, 10(1): 59-64.
    83. Mhandire, D., Lacerda, M., Castel, S.A., Mhandire, K., Zhou, D., Swart, M., Shamu, T., Smith, P., Musingwini, T., Wiesner, L., Stray-Pedersen, S.P.B. and Dandara, C. 2015. Effects of CYP2B6 and CYP1A2 genetic variation on Nevirapine plasma concentration and pharmacodynamics as measured by CD4 cell count in Zimbabwean HIV-infected patients. Omics-A Journal of Integrative Biology, 19(9): 553-562.
    84. Middelkoop, K., Mathema, B., Myer, L., Shashkina, E., Whitelaw, A., Kaplan, G., Kreiswirth, B., Wood, R. and Bekker, L. 2015. Transmission of tuberculosis in a South African community with a high prevalence of HIV infection. Journal of Infectious Diseases, 211: 53-61.
    85. Miyazaki, T., Panoulas, V., Sato, K., Kawamoto, H., Naganuma, T., Latib, A. and Colombo, A. 2015. In-scaffold restenosis in a previous left main bifurcationn lesion treated with bioresorbable scaffold v-stenting. JACC-Cardiovascular Interventions, 8(1): e7-e10.
    86. Mkoko, P., Mokhele, N., Ntsekhe, M. and Ntusi, N. 2015. Digoxin therapy in the modern management of cardiovascular disease: An unusual but serious complication. SAMJ South African Medical Journal, 105(2): 154.
    87. Mkoko, P. 2015. For external use only. SAMJ South African Medical Journal, 105(2): 155.
    88. Mnguni, A.Y., Engel, M.E., Borkum, M. and Mayosi, B.M. 2015. The effects of angiotensin converting enzyme inhibitors (ACE-I) on Human Nacetyl-Seryl-Sspartyl-Lysyl-Proline (AC-SDKP) levels: a systematic review and meta-analysis. PLoS One, 10(12): e0143338(10pp).
    89. Mocumbi, A.O., Thienemann, F. and Sliwa, K. 2015. A global perspective on the epidemiology of pulmonary hypertension. Canadian Journal of Cardiology, 31: 375-381.
    90. Modongo, C., Pasipanodya, J., Zetola, N., Williams, S.M., Sirugo, G. and Gumbo, T. 2015. Amikacin concentrations predictive of ototoxicity in multidrug-resistant tuberculosis patients. Antimicrobial Agents and Chemotherapy, 59: 6337-6343.
    91. Moens, K., Siegert, R., Taylor, S., Namisango, E., Selman, L., Harding, R., Godfrey, A., Natalya, D., Downing, J., Gwyther, E., Keletso, M., Moll, T., Mashao, T., Mpanga Sebuyira, L., Ikin, B. and Higginson, I. 2015. Symptom clusters in people living with HIV attending five palliative care facilities in two sub-Saharan African countries: a hierarchical cluster analysis. PLoS One, 10(5): e0126554(12pp).
    92. Mogueo, A., Echouffo-Tcheugui, J.B., Matsha, T.E., Erasmus, R.T. and Kengne, A.P. 2015. Validation of two prediction models of undiagnosed chronic kidney disease in mixed-ancestry South Africans. BMC Nephrology, 16: 94(14pp).
    93. Molefi, M., Chofle, A.A., Molloy, S.F., Kulluvya, S., Changalucha, J., Cainelli, F., Leeme, T., Lekwape, N., Goldberg, D.W., Haverkamp, M., Bisson, G.P., Perfect, J.R., Letang, E., Fenner, L., Meintjies, G., Burton, R., Makadzange, T., Ndhlovu, C.E., Hope, W., Harrison, T.S. and Jarvis, J.N. 2015. AMBITION-cm: Intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial. Trials, 16(276): 1-10.
    94. Mombaur, B., Lesosky, M., Liebenberg, L., Vreede, H.W. and Heckmann, J.M. 2015. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa. Muscle & Nerve, 51: 533-537.
    95. Moodie, Z., Metch, B., Bekker, L., Churchyard, G.J., Nchabeleng, M., Mlisana, K., Laher, F., Roux, S.M., Mngadi, K., Innes, C., Mathebula, M., Allen, M., Bentley, C., Gilbert, P.B., Robertson, M., Kublin, J., Corey, L. and Gray, G. 2015. Continued follow-up of Phambili phase 2b randomized HIV-1 vaccine trial participants supports increased HIV-1 acquisition among vaccinated men. PLoS One, 10(9): e0137666(14pp).
    96. Moosajee, F. and Kalla, A.A. 2015. Approach to lower back pain. SAMJ South African Medical Journal, 105(12): 1077(3pp).
    97. Murphy, K., Chuma, T., Mathews, C., Steyn, K. and Levitt, N. 2015. A qualitative study of the experiences of care and motivation for effective self-management among diabetic and hypertensive patients attending public sector primary health care services in South Africa. BMC Health Services Research, 15: 303(9pp).
    98. Moultrie, H., McIlleron, H., Sawry, S., Kellermann, T.A., Wiesner, L., Kindra, G., Gous, H. and Van Rie, A. 2015. Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir. Journal of Antimicrobial Chemotherapy, 70: 543-549.
    99. Mouton, J.P., Mehta, U.C., Parrish, A.G., Wilson, D., Stewart, A., Njuguna, C., Kramer, N., Maartens, G., Blockman, M. and Cohen, K. 2015. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey. British Journal of Clinical Pharmacology, 80(4): 818-826.
    100. Mthiyane, T., Rustomjee, r., Pym, A., Connolly, C., Onyebujoh, P.C., Theron, G. and Dheda, K. 2015. Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden. International Journal of Infectious Diseases, 36: 46-53.
    101. Muller, E., Barday, Z., Mendelson, M. and Kahn, D. 2015. HIV-positive-to-HIV-positive kidney transplantation-results at 3 to 5 years. New England Journal of Medicine, 372: 613-620.
    102. Mulligan, K., Glidden, D.V., Anderson, P.L., Liu, A., McMahan, V., Gonzales, P., Ramirez-Cardich, M.E., Namwongprom, S., Chodacki, P., de Mendonca, L.M.C., Wang, F., Lama, J.R., Chariyalertsak, S., Guanira, J.V., Buchbinder, S.P., Bekker, L., Schechter, M., Veloso, V.G. and Grant, R. 2015. Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases, 61(4): 572-580.
    103. Mungwira, R.G., Nyangulu, W., Misiri, J., Iphani, S., Ng'Ong'Ola, R., Chirambo, C.M., Masiye, F. and Mfutso-Bengo, J. 2015. Is it ethical to prevent secondary use of stored biological samples and data derived from consenting research participants? The case of Malawi. BMC Medical Ethics, 16: 83(7pp).
    104. Myat, A., Arri, S., Bhatt, D.L., Gersh, B., Redwood, S. and Marber, M.S. 2015. Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to improve coronary haemodynamics during exercise stress (LIONESS) crossover study. Cardiovascular Diabetology, 14: 27(12pp).
    105. Myer, L., Phillips, T., Manuelli, V., McIntyre, J.A., Bekker, L. and Abrams, E.J. 2015. Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa. Jaids-Journal of Acquired Immune Deficiency Syndromes, 69: e57-e65.
    106. Myers, L., Phillips, T., Hsiao, N.M., Zerbe, A., Petro, G.A., Bekker, L., McIntyre, J.A. and Abrams, E. 2015. Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa. Journal of the International AIDS Society, 18: 20045(5pp).
    107. Mzinza, D.T., Sloan, D., Jambo, K.C., Shani, D., Kamdolozi, M., Wilkinson, K., Wilkinson, R.J., Davies, G.R., Heyderman, R.S. and Mwandumba, H.C. 2015. Kinetics of Mycobacterium tuberculosis-specific IFN-g responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis. Tuberculosis, 95: 463-469.
    108. Nachman, S., Ahmed, A., Amanullah, F., Becerra, M., Botgros, R., Brigden, G., Browning, R., Gardiner, E., Hafner, R., Hesseling, A.C., How, C., Jean-Philippe, P., Lessem, E., Makhene, M., Mbelle, N., Marais, B.J. and McIlleron, H. 2015. Towards early inclusion of children in tuberculosis drugs trials: a consensus statement. Lancet Infectious Diseases, 15: 711-720.
    109. Namale, P., Abdullahi-Hussein, L., Fine, S., Kamkuemah, M.N., Wilkinson, R.J. and Meintjies, G. 2015. Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis. Future Microbiology, 10(6): 1077-1099.
    110. Nansseu, J.R.N., Fokom-Domgue, J., Noubiap, J.J., Balti, E.V., Sobngwi, E. and Kengne, A.P. 2015. Fructosamine measurement for diabetes mellitus diagnosis and monitoring: a systematic review and meta-analysis protocol. BMJ Open, 5: e007689(4pp).
    111. Ndemenge, L., Takah, N.F., Noubiap, J.J., Tindong, M., Ngwasiri, C., Jingi, A.M., Kengne, A.P. and Dzudie, A. 2015. Awareness and low uptake of post exposure prophylaxis for HIV among clinical medical students in a high endemicity setting. BMC Public Health, 15: 1104(9pp).
    112. Ndiaye, B.P., Thienemann, F., Ota, M., Landry, B., Camara, M., Diye, S., Dieye, T.N., Esmail, H., Goliath, R.T., McShane, H., Huygen, K., January, V., Ndiaye, I., Oni, T., Raine, M., Romano, M., Satti, I., Sutton, s., Thiam, A., Wilkinson, K., Mboup, S. and Wilkinson, R.J. 2015. Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial. Lancet Respiratory Medicine, 3: 190-200.
    113. Ndjeka, N., Conradie, F., Schnippel, K., Hughes, J., Bantubani, N., Ferreira, H., Maartens, G., Mametja, D., Meintjies, G., Padanilam, X., Variava, E., Pym, A. and Pillay, Y. 2015. Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. International Journal of Tuberculosis and Lung Disease, 19(8): 979-985.
    114. Ngahane, B.H.M., Nganda, M.M., Dzudie, A., Luma, H., Kamdem, F., Ngote, H.R., Monkam, Y. and Kuaban, C. 2015. Prevalence and determinants of excessive daytime sleepiness in hypertensive patients: a cross-sectional study in Douala, Cameroon. BMJ Open, 5: e008339(5pp).
    115. Nglazi, M., Bekker, L., Wood, R. and Kaplan, R. 2015. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study. BMC Infectious Diseases, 15: 536(8pp).
    116. Nguyen, K., Peer, N., Kengne, A.P. and Mills, E.J. 2015. Burden, determinants, and pharmacological management of hypertension in HIV-positive patients and populations: a systematic narrative review. AIDS Reviews, 17(2): 83-95.
    117. Ngwa, E.N., Kengne, A.P., Tiedeu-Atogho, B., Mofo-Mato, E.-P. and Sobngwi, E. 2015. Persistent organic pollutants as risk factors for type 2 diabetes. Diabetology & Metabolic Syndrome, 7: 41(15pp)
    118. Njuguna, C., Cohen, K. and Maartens, G. 2015. Acute interstitial nephritis caused by lopinavir/ritonavir in a surgeon receiving antiretroviral postexposure prophylaxis. AIDS, 29: 503-506
    119. Nkoke, C., Lekoubou, A., Balti, E.V. and Kengne, A.P. 2015. Stroke mortality and its determinants in a resource-limited setting: a prospective cohort study in Yaounde, Cameroon. Journal of the Neurological Sciences, 358: 113-117.
    120. Noubiap, J.J., Nansseu, J.R.N., Bigna, J.J., Jingi, A.M. and Kengne, A.P. 2015. Prevalence and incidence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis protocol. BMJ Open, 5: e007404(5pp).
    121. Noubiap, J.J., Nansseu, J.R.N., Ndoula, S.T., Bigna, J.J., Jingi, A.M. and Fokom-Domgue, J. 2015. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the far North Region of Cameroon. BMC Public Health, 15: 454(7pp).
    122. Noubiap, J.J., Essouma, M. and Bigna, J.J.R. 2015. Targeting household air pollution for curbing the cardiovascular disease burden: a health priority in sub-Saharan Africa. Journal of Clinical Hypertension, 17(10): 825-829.
    123. Nouya, A.Y., Nansseu, J.R.N., Moor, V.J.A., Pieme, C.A., Noubiap, J.J.N., Tchoula, C.M., Mokette, B.M., Takam, R.D.M., Tankeu, F., Ngogang, J.Y. and Kengne, A.P. 2015. Determinants of fructosamine levels in a multi-ethnic sub-Saharan African population. Diabetes Research and Clinical Practice, 107: 123-129.
    124. Ntsekhe, M., Böhm, M., Mahfoud, F., Ukena, C., Hoppe, U.C., Narkiewicz, K., Negoita, M., Ruilope, R., Schlaich, M.P., Schmieder, R., Whitbourn, R., Williams, B., Zeymer, U.C., Zirlik, A. and Mancia, G. 2015. First report of the Global Symplicity registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension, 65: 766-774.
    125. Ntsekhe, M., Delahaye, F., Chu, V.H., Altclas, J., Barsic, B., Delahaye, A., Freiberger, T., Gordon, D.L., Hannan, M.M., Hoen, B., Kanj, S.S., Lejko-Zupanc, T., Mestres, C.A., Pachirat, O., Pappas, P.A., Lamas, C., Selton-Suty, C., Tan, R., Tattevin, P., Wang, A., Commerford, P.J., Commerford, A., Deetlefs, E. and Hansa, C. 2015. One-year outcome following biological or mechanical valve replacement for infective endocarditis. International Journal of Cardiology, 178: 117-123.
    126. Ntuli, P. and Makambwa, E. 2015. Kounis syndrome. SAMJ South African Medical Journal, 105(10): 878(3pp).
    127. Ntusi, N., Piechnik, S.K., Francis, J.M., Ferreira, V.M., Matthews, P.M., Robson, M.D., Wordsworth, P.B., Neubauer, S. and Karamitsos, T. 2015. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 Mapping. JACC-Cardiovascular Imaging, 8(5): 526-536.
    128. Ntusi, N., Badri, M., Gumedze, F.N., Sliwa, K. and Mayosi, B.M. 2015. Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS One, 10(8): e0133466(13pp).
    129. Offerman, K., Deffur, A., Carulei, O., Wilkinson, R.J., Douglass, N. and Williamson, A.-L. 2015. Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse model. BMC Genomics, 16: 510(20pp).
    130. Ogah, O., Davison, B.A., Sliwa, K., Mayosi, B.M., Damasceno, A., Sani, M., Mondo, C., Dzudie, A., Ojji, D., Kouam, C.K., Suliman, A., Schreuder, N., Yonga, G., Abdou Ba, S., Maru, F., Alemayehu, B., Edwards, C.R.W. and Cotter, G. 2015. Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study. Clinical Research in Cardiology, 104: 481-490.
    131. Ogah, O., Sliwa, K., Akinyemi, J.O., Falase, A.O. and Stewart, S. 2015. Hypertensive heart failure in nigerian Africans: insights from the Abeokuta heart failure registry. Journal of Clinical Hypertension, 17(4): 263-272.
    132. Ojji, D., Atherton, A., Sliwa, K., Alfa, B., Ngabea, M. and Opie, L.H. 2015. Left ventricular systolic dysfunction in asymptomatic black hypertensive subjects. American Journal of Hypertension, 28(7): 924-929.
    133. Ojji, D.B., Libhaber, E., Atherton, A., Abdullahi, B., Nwankwo, A. and Sliwa, K. 2015. Risk-factor profile and comorbidities in 2398 patients with newly diagnosed hypertension from the Abuja heart study. Medicine, 94(39): e1660(9pp).
    134. Okop, K., Levitt, N. and Puoane, T. 2015. Factors associated with excessive body fat in men and women: cross-sectional data from black South Africans living in a rural community and an urban township. PLoS One, 10(10): e0140153(17pp).
    135. Okpechi, I.G., Swanepoel, C.R. and Venter, W.D. 2015. Access to medications and conducting clinical trials in LMICs. Nature Reviews Nephrology, 11: 189-194.
    136. Okpechi, I.G., Gcelu, A. and Ameh, O. 2015. Lupus nephritis: an approach to diagnosis and treatment in South Africa. SAMJ South African Medical Journal, 105(12): 1071(4pp).
    137. Ongarora, D., Strydom, N., Wicht, K., Njoroge, M., Wiesner, J., Egan, T.J., Wittlin, S., Jurva, U., Masimirembwa, C.M. and Chibale, K. 2015. Antimalarial benzoheterocyclic 4-aminoquinolines: structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies. Bioorganic & Medicinal Chemistry, 23: 5419-5432.
    138. Oni, T. and Ehrlich, R.I. 2015. Complicated silicotuberculosis in a South African gold miner: a case report. American Journal of Industrial Medicine, 58: 697-701.
    139. Oni, T., Boulle, A.M., McGrath, N., Wilkinson, R.J., Levitt, N. and Youngblood, E. 2015. Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study. BMC Infectious Diseases, 15: 20(8pp).
    140. Opie, L.H. 2015. Digitalis reappraised: still here today, but gone tomorrow? SAMJ South African Medical Journal, 105(2): 88-89.
    141. Opie, L.H. 2015. A proposal to incorporate trial data into a hybrid American college of cardiology/American heart association algorithm for the allocation of statin therapy in primary prevention. JACC: Heart Failure, 66(12): 1408-1413.
    142. Opie, L.H. 2015. Melatonin, the new partner to aspirin? Lancet, 385(9970): 774.
    143. Opie, L.H. 2015. Heart health: diets and lifestyle. Transactions of the Royal Society of South Africa, 70(1): 79-82.
    144. Opie, L.H. 2015. Present status of statin therapy. Trends in Cardiovascular Medicine, 25: 216-225.
    145. Opie, L.H. and Lopaschuk, G. 2015. What is good for the circulation also lessens cancer risk. European Heart Journal, 36: 1157-1162.
    146. Orrell, C., Cohen, K., Mauff, K.A.L., Bangsberg, D.R., Maartens, G. and Wood, R. 2015. A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. Jaids-Journal of Acquired Immune Deficiency Syndromes, 70: 495-502.
    147. Orren, A., Thomas, A., Leisegang, F., Wurzner, R., Owen, E.P. and Potter, P.C. 2015. South African patients with genetic deficiencies of complement components C5 and C6 suffer a marked increase in susceptibility to meningococcal disease. Current Allergy & Clinical Immunology, 28(3): 192-194.
    148. Owen, P., Wurzner, R., Leisegang, F., Rizkallah, P., Whitelaw, A.C., Simpson, J., Thomas, A., Harris, C.L., Giles, J.L., Hellerud, B.C., Mollnes, T.E., Morgan, B.P., Potter, P.C. and Orren, A. 2015. A complement C5 gene mutation, c.754G>A:p.A252T, is common in the Western Cape, South Africa and found to be homozygous in seven percent of Black African meningococcal disease cases. Molecular Immunology, 64: 170-176.
  • P - T

    1. Pandie, S., Mehta, S.R., Cantor, W.J., Cheema, A.N., Gao, P., Madan, M., Niemela, N., Rao, S.V., Schwalm, J.D., Valentin, V., Velianou, J.L. and Jolly, S.S. 2015. Radial versus femoral access for coronary angiography/intervention in women with acute coronary syndromes. Insights from the RIVAL trial (Radial vs femorAL access for coronary intervention). JACC-Cardiovascular Interventions, 8(4): 505-512.
    2. Le Manach, C., Paquet, T., Brunschwig, C., Njoroge, M., Han, Z., Cabrera, D.G., Bashyam, S., Dhinakaran, R., Taylor, D., Reader, J., Botha, M., Churchyard, A., Lauterbach, S., Coetzer, T.L., Birkholtz, L.-M., Meister, S., Winzeler, E.A., Waterson, D., Witty, M.J., Wittlin, S., Jimnez-Daz, M., Santos Martnez, M., Ferrer, S., Angulo-Barturen, I., Street, L.J. and Chibale, K. 2015. A novel pyrazolopyridine with in vivo activity in Plasmodium berghei - and Plasmodium falciparum-infected mouse models from structure-activity relationship studies around the core of recently identified antimalarial Imidazopyridazines. Journal of Medicinal Chemistry, 58: 8713-8722.
    3. Pasipanodya, J., Hall 2nd, R.G. and Gumbo, T. 2015. In silico-derived bedside formula for individualized micafungin dosing for obese patients in the age of deterministic chaos. Clinical Pharmacology & Therapeutics, 97(3): 292-297.
    4. Pasipanodya, J.G., Nuermberger, E., Romero, K., Hanna, D. and Gumbo, T. 2015. Systematic analysis of hollow fiber model of Tuberculosis experiments. Clinical Infectious Diseases, 61(Suppl 1): S10-S17.
    5. Peer, N., Lombard, C., Steyn, K. and Levitt, N. 2015. High prevalence of metabolic syndrome in the Black population of Cape Town: the cardiovascular risk in black South Africans (CRIBSA) study. European Journal of Preventive Cardiology, 22(8): 1036-1042.
    6. Pefura-Yone, E.W., Kuaban, C., Assamba-Mpom, S.A., Moifo, B. and Kengne, A.P. 2015. Derivation, validation and comparative performance of a simplified chest X-ray score for assessing the severity and outcome of pulmonary tuberculosis. Clinical Respiratory Journal, 9: 157-164.
    7. Pefura-Yone, E.W., Mbele-Onana, C.L., Balkissou, A.D., Kenmegne-Noumsi, E.C., Boulleys-Nana, J.R., Kolontchang-Yomi, B.L., Theubo-Kamgang, B.J., Ndjeutcheu-Moualeu, P.I., Ebouki, E.R. and Kengne, A.P. 2015. Perennial aeroallergens sensitisation and risk of asthma in African children and adolescents: a case-control study. Journal of Asthma, 52(6): 571-575.
    8. Pefura-Yone, E.W., Fodjeu, G., Kengne, A.P., Roche, N. and Kuaban, C. 2015. Prevalence and determinants of chronic obstructive pulmonary disease in HIV infected patients in an African country with low level of tobacco smoking. Respiratory Medicine, 109: 247-254.
    9. Pefura-Yone, E.W., Kengne, A.P., Balkissou, A.D., Boulleys-Nana, J.R., Efe-de-Melingui, N.R., Ndjeutcheu-Moualeu, P.I., Mbele-Onana, C.L., Kenmegne-Noumsi, E.C., Kolontchang-Yomi, B.L., Theubo-Kamgang, B.J., Ebouki, E.R., Djuikam-Kamga, C.K., Magne-Fotso, C.G., Amougou, F., Mboumtou, L., Ngo-Yonga, M., Petchou-Talla, E.L., Afane-Ze, E., Kuaban, C. and Research Group for Respiratory Disease in Cameroon, R.G.R.D.C. 2015. Prevalence of asthma and allergic rhinitis among adults in Yaounde, Cameroon. PLoS One, 10(4): e0123099(15pp).
    10. Pepper, D.J., Schomaker, M., Wilkinson, R.J., de Azevedo, V. and Maartens, G. 2015. Independent predictors oftuberculosis mortality ina high HIV prevalence setting: a retrospective cohort study. AIDS Research and Therapy, 12: 35(9pp).
    11. Peter, J. 2015. Common variable immunodeficiency in South Africa. Current Allergy & Clinical Immunology, 28(3): 216-222.
    12. Peter, J., Dlamini, S.K. and Lehloenya, R.J. 2015. A South African multidisciplinary drug hypersensitivity clinic. Current Allergy & Clinical Immunology, 28(4): 270-274.
    13. Peter, J., Theron, G., Chanda, D., Clowes, P., Rachow, A., Lesosky, M., Hoelscher, M., Mwaba, P., Pym, A. and Dheda, K. 2015. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing. BMC Infectious Diseases, 15: 262(12pp).
    14. Peter, J., Mouton, J.P. and Lehloenya, R. 2015. Immune-mediated adverse drug reactions in South Africa. Current Allergy & Clinical Immunology, 28(3): 186-190.
    15. Philipsen, R.H.H.M., Sanchez, C.I., Maduskar, P., Melendez, J., Peters-Bax, L., Peter, J., Dawson, R., Theron, G., Dheda, K. and van Ginneken, B. 2015. Automated chest-radiography as a triage for Xpert testing in resource-constrained settings: a prospective study of diagnostic accuracy and costs. Scientific Reports, 5: 12215(8pp).
    16. Pietersen, E., Peter, J., Streicher, E.M., Sirgel, F., Rockwood, N., Mastrapa, B., Riele, J., Davids, M., van Helden, P., Warren, R.M. and Dheda, K. 2015. High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis. PLoS One, 10(4): e0123655(13pp).
    17. Pisano, F., Altomare, C., Cervio, E., Barile, L., Rocchetti, M., Ciuffreda, M.C., Malpasso, G., Copes, F., Mura, M., Danieli, P., Viarengo, G., Zaza, A. and Gnecchi, M. 2015. Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation. Stem Cells, 33: 1187-1199.
    18. Poncet, A., Gencer, B., Blondon, M., Gex-Fabry, M., Combescure, C., Shah, D., Schwartz, P.J., Besson, M. and Girardin, F.R. 2015. Electrocardiographic screening for prolonged QT interval to reduce sudden cardiac death in psychiatric patients: a cost-effectiveness analysis. PLoS One, 10(6): e0127213 (14pp).
    19. Porter, M., Davies, M., Mapani, M., Rabie, H., Phiri, S., Nuttall, J.J., Technau, K.-G., Fairlie, L., Stinson, K., Wood, R., Wellington, M., Haas, A.D., Giddy, J., Tanser, F. and Eley, B.S. 2015. Outcomes of infants starting antiretroviral therapy in Southern Africa, 2004-2012. Jaids-Journal of Acquired Immune Deficiency Syndromes, 69(5): 593-601.
    20. Potter, P.C., Baker, S., Fenemore, B. and Nurse, B. 2015. Clinical and cytokine responses to house dust mite sublingual immunotherapy. Annals of Allergy Asthma & Immunology, 114: 327-334.
    21. Potter, P.C., Ehrlich, R.I., van Rooyen, C. and Fenemore, B. 2015. Occupational sensitization to African penguin serum and mucus proteins. Annals of Allergy Asthma & Immunology, 114: 345-347.
    22. Pretorius, S., Stewart, S., Carrington, M., Lamont, K., Sliwa, K. and Crowther, N.J. 2015. Is there an association between sleeping patterns and other environmental factors with obesity and blood pressure in an urban African population? PLoS One, 10(10): e0131081(14pp).
    23. Prudence, I., Mendelson, M. and Dlamini, S.K. 2015. Fever, sore throat and myalgia. SAMJ South African Medical Journal, 105(2): 157-158.
    24. Pule, G.D., Ngo Bitoungui, V.J., Chemegni, B.C., Kengne, A.P., Antonarakis, S. and Wonkam, A. 2015. Association between variants at BCL11A erythroid-specific enhancer and fetal hemoglobin levels among Sickle Cell disease patients in Cameroon: implications for future therapeutic interventions. Omics-A Journal of Integrative Biology, 19(10): 627-631.
    25. Raal, F.J. and Blom, D. 2015. Anacetrapib in familial hypercholesterolaemia: pros and cons. Comment. Lancet, 385: 2124-2126.
    26. Raal, F.J., Honarpour, N., Blom, D., Hovingh, G.K., Xu, F., Scott, R., Wasserman, S.M. and Stein, E.A. 2015. Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial. Lancet, 385: 341-350.
    27. Rangaka, M.X., Cavalcante, S.C., Marais, B.J., Thim, S., Martinson, N.A., Swaminathan, S. and Chaisson, R. 2015. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet, 386: 2344-2353.
    28. Rapeport, N., Schamroth, C. and Blom, D. 2015. Gender and ethnic differences in the control of hyper-lipidaemia and other vascular risk factors: insights from the CEntralised Pan-South African survey on tHE Under-treatment of hypercholeSterolaemia (CEPHEUS SA) study. The South African Journal of Diabetes & Vascular Disease, 12: 30-34.
    29. Rautenbach, C., Lindegger, G., Slack, C., Wallace, M. and Newman, P. 2015. I’m positive, but I’m negative: competing voices in informed consent and implications for HIV vaccine trials. Journal of Empirical Research on Human Research Ethics, 10(2): 151-156.
    30. Ravinetto, R., De Nys, K., Boelaert, M., Diro, E., Meintjes, G., Adoke, Y., Tagbor, H. and Casteels, M. 2015. Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines. BMC International Health and Human Rights, 15: 34(7pp).
    31. Rayner, B.L. and Ramesar, R.S. 2015. The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment. International Journal of Molecular Sciences, 16: 5741-5749.
    32. Rebe, K.B., Lewis, D.A., Myer, L., de Swardt, G., Struthers, H., Kamkuemah, M. and McIntyre, J.A. 2015. A cross sectional analysis of gonococcal and chlamydial infections among men-who-have-sex-with-men in Cape Town, South Africa. PLoS One, 10(9): e0138315(12pp).
    33. Reddel, H.K., Bateman, E.D., Becker, A., Boulet, L.-P., Cruz, A.A., Drazen, J.M., Haahtela, T., Hurd, S.S., Inoue, H., de Jongste, J.C., Lemanske Jr, R.F., Levy, M.L., O'Byrne, P.M., Paggiaro, P., Pedersen, S., Pizzichini, E., Soto-Quiroz, M., Szefler, S.J., Wong, G. and FitzGerald, J.M. 2015. A summary of the new GINA strategy: a roadmap to asthma control. European Respiratory Journal, 46: 579-582.
    34. Rider, O.J., Lewis, A.J.M., Lewandowski, A.J., Ntusi, N., Nethononda, R., Petersen, S.E., Francis, J.M., Pitcher, A.J., Banerjee, R., Leeson, P. and Neubauer, S. 2015. Obese subjects show sex-specific differences in right ventricular hypertrophy. Circulation-Cardiovascular Imaging, 8: e002454(9pp).
    35. Ritchie, P.L.M., Schull, M.J., Martiniuk, A.L., Barnsley, J., Arenovich, T., van Lettow, M., Chan, A.K., Mills, E., Makwakwa, A. and Zwarenstein, M. 2015. A knowledge translation intervention to improve tuberculosis care and outcomes in Malawi: a pragmatic cluster randomized controlled trial. Implementation Science, 10: 38(10pp).
    36. Robins, A.H. and Holland, M. 2015. The art of medicine: The enigmatic illness and death of Constance, wife of Oscar Wilde. Lancet, 385: 21-22.
    37. Rockwood, N., Abdullahi-Hussein, L., Wilkinson, R.J. and Meintjes, G. 2015. Risk factors for acquired rifamycin and isoniazid resistance: a systematic review and meta-analysis. PLoS One, 10(9): e0139017(23pp).
    38. Roos-Hesselink, J.W., Cornette, J., Sliwa, K., Pieper, P., Veldtman, G.R. and Johnson, M.R. 2015. Contraception and cardiovascular disease. European Heart Journal, 36: 1728-1734.
    39. Ross, I.L. and Louw, G.J. 2015. Embryological and molecular development of theadrenal glands. Clinical Anatomy, 28: 235-242.
    40. Rush, C. and Ntsekhe, M. 2015. Case report a lady with a broken heart: Apical ballooning syndrome. SAMJ South African Medical Journal, 105(5): 422.
    41. Sabatine, M., Giugliano, R.P., Wiviott, S., Raal, F., Blom, D., Robinson, J., Ballantyne, C.M., Somaratne, R., Legg, J., Wasserman, S.M., Scott, R., Koren, M.J. and Stein, E.A. 2015. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. New England Journal of Medicine, 372: 1500-1509.
    42. Sampson, L., van der Schyff, N. and Cupido, C. 2015. The unsuspected killer: Liquefied petroleum gas overexposure in South Africa. SAMJ South African Medical Journal, 105(2): 152-152.
    43. Sampson, U.K.A., Harrell, F.E., Fazio, S., Nwosu, S., Mercaldo, N., Mensah, G., Davidson, M.H., Coll, B. and Feinstein, S.B. 2015. Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population. Echocardiography-A Journal of Cardiovascular Ultrasound and Allied Techniques, 32: 264-270.
    44. Saraswat, V., Norris, S., De Knegt, R.J., Sanchez Avila, A., Sonderup, M., Zuckerman, E., Arkkila, P., Stedman, C., Acharya, S., Aho, I., Anand, A.C. and Spearman, C. 2015. Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2. Journal of Viral Hepatitis, 22(Suppl 1): 6-25.
    45. Sathyamoorthy, T., Tezera, L.B., Walker, N.F., Brilha, S., Saraiva, L., Mauri, M.A., Wilkinson, R.J., Friedland, J.S. and Elkington, P.T.G. 2015. Membrane type 1 matrix metalloproteinase regulates monocyte migration and collagen destruction in tuberculosis. Journal of Immunology, 195: 882-891.
    46. Savic, R.M., Ruslami, R., Hesseling, A.C., Ramachandran, G., Ganiem, A.R., Swaminathan, S., McIlleron, H., Gupta, A., Thakur, K., Van Crevel, R., Aarnoutse, R. and Dooley, K.E. 2015. Pediatric Tuberculous Meningitis: model-based approach to determining optimal doses of the anti-Tuberculosis drugs Rifampin and Levofloxacin for children. Clinical Pharmacology & Therapeutics, 98(6): 622-629.
    47. Schwartz, I.S., Kenyon, C., Feng, P., Govender, N., Dukik, K., Sigler, L., Jiang, Y., Stielow, J.B., Muoz, J.F., Cuomo, C.A., Botha, A. and Stchigel, A.M. 2015. 50 Years of Emmonsia disease in humans: the dramatic emergence of cluster of novel fungal pathogens. PLOS Pathogens, 11(11): e1005198(8pp).
    48. Schwartz, I.S., Govender, N., Corcoran, C., Dlamini, S.K., Prozesky, H., Burton, R., Mendelson, M., Taljaard, J., Lehloenya, R., Calligaro, G.L., Colebunders, R. and Kenyon, C. 2015. Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series. Clinical Infectious Diseases, 61(6): 1004-1012.
    49. Schwartz, P.J., La Rovere, M.T., De Ferrari, G.M. and Mann, D.L. 2015. Autonomic Modulation for the Management of Patients with Chronic Heart Failure. Circulation-Heart Failure, 8: 619-628.
    50. Scott Millar, R.N. and Chin, A. 2015. Rhythms of the heart: the history of electrophysiology and itscurrent status in South Africa. SA Heart, 12(3): 156-163.
    51. Scriven, J., Rhein, J., Hullsiek, K.H., von Hohenberg, M., Linder, G., Rolfes, M., Williams, D., Taseera, K., Meya, D.B., Meintjes, G. and Boulware, D.R. 2015. Early ART after cryptococcal meningitis is associated with cerebrospinal fluid pleocytosis and macrophage activation in a multisite randomized trial. Journal of Infectious Diseases, 212: 769-778.
    52. Senthilingam, M., Pietersen, E., McNerney, R., Riele, J., Sedres, P., Wilson, R. and Dheda, K. 2015. Lifestyle, attitudes and needs of uncured XDR-TB patients living in the communities of South Africa: a qualitative study. Tropical Medicine & International Health, 20(9): 1155-1161.
    53. Sieglera, A.J., Sullivan, P., de Voux, A., Phaswana-Mafuya, N., Bekker, L., Baral, S., Winskell, K., Kose, Z., Wirtz, A.L., Brown, B. and Stephenson, R. 2015. Exploring repeat HIV testing among men who have sex with men in Cape Town and Port Elizabeth, South Africa. Aids Care, 27(2): 229-234.
    54. Sigurgeirsson, B., Boznanski, A., Todd, G., Vertruyen, A., Schuttelaar, M.A., Zhu, X., Schauer, U., Qaqundah, P., Poulin, Y., Kristjansson, S., Von Berg, A., Nieto, A., Boguniewicz, M., Paller, A.S., Dakovic, R., Ring, J. and Luger, T. 2015. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics, 135(4): 597-606.
    55. Silal, S., Little, F., Barnes, K.I. and White, L.J. 2015. Hitting a moving target: a model for malaria elimination in the presence of population movement. PLoS One, 10(12): e0144990(16pp).
    56. Silal, S.P., Little, F., Barnes, K.I. and White, L.J. 2015. Predicting the impact of border control on malaria transmission: a simulated focal screen and treat campaign. Malaria Journal, 14: 1-14.
    57. Sinxadi, P., Leger, P.D., McIlleron, H., Smith, P.J., Dave, J.A., Levitt, N., Maartens, G. and Haas, D.W. 2015. Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa. British Journal of Clinical Pharmacology, 80(1): 146-156.
    58. Siontis, K.C., Geske, J.B. and Gersh, B. 2015. Atrial fibrillation pathophysiology and prognosis insights from cardiovascular imaging. Circulation-Cardiovascular Imaging, 8: e003020(10pp).
    59. Sliwa, K., Matzopoulos, R., Kengne, A.P., Mayosi, B.M. and Stein, D.J. 2015. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet, 386: 2145-2191.
    60. Sliwa, K. and Hilfiker-Kleiner, D. 2015. Cord Blood Samples: A less explored tool in early diagnosis of neonatal cardiovascular disease. Journal of the American College of Cardiology, 66(8): 940-942.
    61. Sliwa, K. 2015. Dealing with late maternal death due to cardiovascular disease. SA Heart, 12(3): 130-133.
    62. Sliwa, K., Mayosi, B.M., Naghavi, M., Wang, H. and Lozano, R. 2015. Global, regional, and national age sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385: 117-171.
    63. Sliwa, K., Johnson, M.R., Zilla, P. and Roos-Hesselink, J.W. 2015. Management of valvular disease in pregnancy: A global perspective. European Heart Journal, 36: 1078-1089.
    64. Smit, W., De Lannoy, A.M.F.A., Dover, R.V.H., Lambert, E.V., Levitt, N. and Watson, V.J. 2015. Making unhealthy places: The built environment and non-communicable diseases in Khayelitsha, Cape Town. Health & Place, 35: 11-18.
    65. Smit, W., De Lannoy, A., Dover, R.V.H., Lambert, E.V., Levitt, N. and Watson, V.J. 2015. Making unhealthy places: the built environment and non-communicable diseases in Khayelitsha, Cape Town. Health & Place, 35: 11-18.
    66. Smith, A., de Jager, C.A., Refsum, H. and Rosenberg, I.H. 2015. Homocysteine lowering, B vitamins, and cognitive aging. American Journal of Clinical Nutrition, 101(2): 415-416.
    67. Sonderup, M.W., Wainwright, H.C., Hall, P., Hairwadzi, H. and Spearman, W. 2015. A clinicopathological cohort study of liver pathology in 301 patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome. Hepatology, 61: 1721-1729.
    68. Sorsdahl, K., Petersen Williams, P., Everett-Murphy, K., Vythilingum, B., de Villiers, P., Myers, B.J. and Stein, D.J. 2015. Feasibility and preliminary responses to a screening and brief intervention program for maternal mental disorders within the context of primary care. Community Mental Health Journal, 51: 962-969.
    69. Spearman, W. and Sonderup, M.W. 2015. Health disparities in liver disease in sub-Saharan Africa. Liver International, 35: 2063-2071.
    70. Srivastava, S., Pasipanodya, J.G., Sherman, C.M., Meek, C., Leff, R. and Gumbo, T. 2015. Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular mycobacterium kansasii disease. Antimicrobial Agents and Chemotherapy, 59(4): 2273-2279.
    71. Stefanutti, C., Blom, D., Averna, M.R., Meagher, E.A., du Toit Theron, H., Marais, A.D., Hegele, R.A., Sirtori, C.R., Shah, P.K., Gaudet, D., Vigna, G.B., Sachais, B., Giacomo, S.D., Du Plessis, A.M.E., Bloedon, L.T., Balser, J., Rader, D.J. and Cuchel, M. 2015. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial. Atherosclerosis, 240: 408-414.
    72. Streicher, E.M., Sampson, S.L., Dheda, K., Dolby, T., Simpson, J., Victor, T.C., Gey van Pittius, N.C., Van Helden, P. and Warren, R.M. 2015. Molecular epidemiological interpretation of the epidemic of extensively drug-resistant tuberculosis in South Africa. Journal of Clinical Microbiology, 53(11): 3650-3653.
    73. Stringer, T., Taylor, D., Guzgay, H., Shokar, A., Au, A., Smith, P.J., Hendricks, D.T., Land, K.M., Egan, T.J. and Smith, G.S. 2015. Polyamine quinoline rhodium complexes: synthesis and pharmacological evaluation as antiparasitic agents against plasmodium falciparum and trichomonas vaginalis. Dalton Transactions, 44: 14906-14917.
    74. Stringer, T., Guzgay, H., Combrinck, J.M., Hopper, M., Hendricks, D.T., Smith, P.J., Land, K.M., Egan, T.J. and Smith, G.S. 2015. Synthesis, characterization and pharmacological evaluation of ferrocenyl azines and their rhodium(I) complexes. Journal of Organometallic Chemistry, 788: 1-8.
    75. Subbarao, S., Wilkinson, K., van Halsema, C.L., Rao, S.S., Boyles, T.H., Utay, N.S., Wilkinson, R.J. and Meintjies, G. 2015. Raised venous lactate and markers of intestinaltranslocation are associated with mortality amongin-patients with HIV-associated TB in rural South Africa. Jaids-Journal of Acquired Immune Deficiency Syndromes, 70(4): 406-413.
    76. Subbian, S., Tsenova, L., Kim, M.-J., Wainwright, H.C., Visser, A., Bandyopadhyay, N., Bader, J.S., Karakousis, P., Murrmann, G.B., Bekker, L., Russell, D.G. and Kaplan, G. 2015. Lesion-specific immune response in granulomas of patients with pulmonary tuberculosis: a pilot study. PLoS One, 10(7): e0132249(21pp).
    77. Surka, S., Steyn, K., Everett-Murphy, K., Gaziano, T.A. and Levitt, N. 2015. Knowledge and perceptions of risk for cardiovascular disease: findings of a qualitative investigation from a low-income peri-urban community in the Western Cape, South Africa. African Journal of Primary Health Care & Family Medicine, 7(1): 891(8pp).
    78. Taleli, L., De Kock, C., Smith, P.J., Pelly, S.C., Blackie, A.L. and van Otterlo, W.A.L. 2015. In vitro antiplasmodial activity of triazole-linked chloroquinoline derivatives synthesized from 7-chloro-N-(prop-2-yn-1-yl) quinolin-4-amine. Bioorganic & Medicinal Chemistry, 23: 4163-4171.
    79. Tameris, M.D., Hokey, D.A., Nduba, V., Sacarlal, J., Laher, F., Kiringa, G., Gondo, K., Lazarus, E., Gray, G.E., Nachman, S., Mahomed, H., Downing, K.J., Abel, B., Scriba, T., McClain, J., Pau, M.G., Hendriks, J., Dheenadhayala, V., Ishmukhamedov, S., Luabeya, K.K.A., Geldenhuys, H.D., Shepherd, B., Blatner, G., Cardenas, V., Walker, R., Hanekom, W.A., Sadoff, J.C., Douoguih, M., Barker, L. and Hatherill, M. 2015. A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. Vaccine, 33: 2944-2954.
    80. Tchoubi, S., Sobngwi-Tambekou, J., Noubiap, J.J., Asangbeh, S.L., Nkoum, B.A. and Sobngwi, E. 2015. Prevalence and risk factors of overweight and obesity among children aged 659 months in Cameroon: a multistage, stratified cluster sampling nationwide survey. PLoS One, 10(12): e0143215(16pp).
    81. Thee, S., Garcia-Prats, A.J., Draper, H.R., McIlleron, H., Wiesner, L., Castel, S.A., Schaa, S.H. and Hesseling, A.C. 2015. Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis. Clinical Infectious Diseases, 60(4): 549-556.
    82. Theron, G., Jenkins, H.E., Cobelens, F., Abubakar, I., Khan, A.J., Cohen, T. and Dowdy, D.W. 2015. Data for action: collection and use of local data to end tuberculosis. Lancet, 386: 2324-2333.
    83. Theron, G., Peter, J., Zijenah, L., Chanda, D., Mangu, C.D., Clowes, P., Rachow, A., Lesosky, M., Hoelscher, M., Pym, A., Mwaba, P., Mason, P.R., Naidoo, P., Pooran, A., Sohn, H., Pai, M., Stein, D.J. and Dheda, K. 2015. Psychological distress and its relationship with non-adherence to TB treatment: a multicentre study. BMC Infectious Diseases, 15: 253(12pp).
    84. Tikly, M., Hodkinson, B. and Dheda, K. 2015. Biologic therapy for rheumatoid arthritis in developing countries - a place for non-TNF inhibitors as first-line treatment? Rheumatology, 54: 208-209.
    85. Tindana, P., de Vries, J., Campbell, M.M., Littler, K., Seeley, J., Marshall, P., Troyer, J., Ogundipe, M., Alibu, V.P., Yakubu, A. and Parker, M. 2015. Community engagement strategies for genomic studies in Africa: a review of the literature. BMC Medical Ethics, 16: 24(12pp).
    86. Torrado, E., Fountain, J.J., Liao, M., Tighe, M., Reiley, W.W., Lai, R., Meintjes, G., Pearl, J.E., Chen, X., Zak, D.E., Thompson, E.G., Aderem, A., Ghilardi, N., Solache, A., McKinstry, K.K., Strutt, T.M., Wilkinson, R.J., Swain, S.L. and Cooper, A.M. 2015. Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection. Journal of Experimental Medicine, 212(9): 1449-1463.
    87. Torres, M., Garcia-Garcia, L., Cruz-Hervert, P., Guio, H., Carranza, C., Ferreyra-Reyes, L., Canizales, S., Molina, S., Ferreira-Guerrer, E., Tellez, N., Montero-Campos, R., Delgado-Sanchez, G., Mongua-Rodriguez, N., Sifuentes-Osornio, J., Ponce-de-Leon, A., Sada, E., Young, D.B. and Wilkinson, R.J. 2015. Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis. European Respiratory Journal, 45: 473-482.
  • U - Z

    1. Uthman, O.A., Wiysonge, C., Ota, O., Nicol, M.P., Hussey, G.D., Ndumbe, P.M. and Mayosi, B.M. 2015. Increasing the value of health research in the WHO African Region beyond 2015 - reflecting on the past, celebrating the present and building the future: a bibliometric analysis. BMJ Open, 5: e006340(70pp).
    2. van Dam, J., Musuku, J., Zuhlke, L., Engel, M.E., Nestle, N., Tadmor, B., Spector, J. and Mayosi, B.M. 2015. An open-access, mobile compatible, electronic patient register for rheumatic heart disease (eRegister) based on the World Heart Federations framework for patient registers. Cardiovascular Journal of Africa, 26(6): 227-233.
    3. van der Leeuw, J., Visseren, F.L.J., Woodward, M., Zoungas, S., Kengne, A.P., van der Graaf, Y., Glaziou, P., Hamet, P., Macmahon, S., Poulter, N., Grobbee, D.E. and Chalmers, J. 2015. Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus results from action in diabetes and vascular disease: preterax and diamicron MR controlled evaluation. Hypertension, 65: 115-121.
    4. van der Straten, A., Montgomery, E.T., Musara, P., Etima, J., Naidoo, S., Laborde, N., Hartmann, M., Levy, L., Bennie, T., Cheng, H., Piper, J., Grossman, C., Marrazzo, J. and Mensch, B. 2015. Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS, 29: 2161-2171.
    5. Van Der Walt, I., Swanepoel, C.R., Mahala, B. and Meyers, A.M. 2015. Important complications of chronic kidney disease. SAMJ South African Medical Journal, 105(4): 1-4.
    6. Van Der Watt, J., Benatar, M.G., Harrison, T.B., Carrara, H. and Heckmann, J.M. 2015. Isoniazid exposure and pyridoxine levels in human immunodeficiency virus associated distal sensory neuropathy. International Journal of Tuberculosis and Lung Disease, 19(11): 1312–1319.
    7. van der Westhuizen, F.H., Sinxadi, P., Dandara, C., Smuts, I., Riordan, G.T.M., Meldau, S., Malik, A.N., Sweeney, M.G., Tsai, Y., Towers, G.W., Louw, R., Gorman, G., Payne, B., Soodyall, H. and Pepper, M.S. 2015. Understanding the Implications of Mitochondrial DNA variation in the health of black Southern African populations: the 2014 Workshop. Human Mutation, 36: 569-571.
    8. van der Westhuyzen, R., Winks, S., Wilson, C., Boyle, G., Gessner, R.K., de Melo Soares, C., Taylor, D., De Kock, C., Njoroge, M., Brunschwig, C., Lawrence, N., Rao, S.P.S., Sirgel, F.A., van Helden, P., Seldon, R., Moosa, A., Warner, D., Arista, L., Manjunatha, U.H., Smith, P.W., Street, L.J. and Chibale, K. 2015. Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: a novel antimycobacterial class targeting mycobacterial respiration. Journal of Medicinal Chemistry, 58: 9371-9381.
    9. Van Zyl Smit, R., Naidoo, J., Wainwright, H.C., Said-Hartley, Q.M., Davids, M., Goodman, H.T., Rogers, S. and Dheda, K. 2015. HIV associated Lymphocytic Interstitial Pneumonia: a clinical, histological and radiographic study from an HIV endemic resource-poor setting. BMC Pulmonary Medicine, 15: 38(7pp).
    10. Van Zyl Smit, R. 2015. Chronic obstructive pulmonary disease in South Africa: Under-recognised and undertreated. SAMJ South African Medical Journal, 105(9): 785.
    11. Vandekerckhove, S., Van Herreweghe, S., Willems, J., Danneels, B., Desmet, T., De Kock, C., Smith, P.J., Chibale, K. and D'Hooghe, M. 2015. Synthesis of functionalized 3-, 5-, 6- and 8-aminoquinolines via intermediate (3-pyrrolin-1-yl)- and (2-oxopyrrolidin-1-yl)quinolines and evaluation of their antiplasmodial and antifungal activity. European Journal of Medicinal Chemistry, 92: 91-102.
    12. Veale, C.G.L., Edkins, A.L., de la Mare, J.-A., De Kock, C., Smith, P.J. and Khanye, S. 2015. Facile synthesis and biological evaluation of assorted indolyl-3-amides and esters from a single, stable carbonyl nitrile intermediate. Tetrahedron Letters, 56: 1860-1864.
    13. Venter, W.D.F., Cowan, F.M., Black, V., Rebe, K. and Bekker, L. 2015. Pre-exposure prophylaxis in Southern Africa: feasible or not? Journal of the International AIDS Society, 18(Suppl 3): 19979(7pp).
    14. Verguet, S., Olson, Z.D., Babigumira, J.B., Desalegn, D., Johansson, K.A., Kruk, M.E., Levin, C., Nugent, R.A., Pecenka, C., Shrime, M.G., Memirie, S.T., Watkins, D.A. and Jamison, D.T. 2015. Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis. The Lancet Global Health, 3: e288-e296.
    15. Vermaak, J., Dave, J.A., Levitt, N. and Heckmann, J.M. 2015. Sensory neuropathy and metabolic risk factors in human immune deficiency virus infected South Africans receiving protease inhibitors. AIDS Research and Therapy, 12: 30(7pp).
    16. Viviers, P.J. and Van Zyl-Smit, R. 2015. Chronic obstructive pulmonary disease diagnosis and classification of severity. SAMJ South African Medical Journal, 105(9): 786-788.
    17. Walker, N.F., Brown, C.S., Youkee, D., Baker, P., Williams, N., Kalawa, A., Russell, K., Samba, A.F., Bentley, N., Koroma, F., King, M.B., Parker, B.E., Thompson, M., Boyles, T.H., Healey, B., Kargbo, B., Bash-Taqi, D., Simpson, A.J., Kamara, A., Kamara, T.B., Lado, M., Johnson, O. and Brooks, T. 2015. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Eurosurveillance, 20(12): 21073(6pp).
    18. Walker, N.F. and Whitty, C.J.M. 2015. Tackling emerging infections: clinical and public health lessons from the West African Ebola virus disease outbreak, 2014-2015. Clinical Medicine, 15(5): 457-460.
    19. Watermeyer, G. and Thomson, S.R. 2015. Granulomas at initial diagnosis of Crohns disease signal a poor outcome. SAMJ South African Medical Journal, 105(6): 480-483.
    20. Watkins, D.A., Mvundura, M., Nordet, P. and Mayosi, B.M. 2015. A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba. PLoS One, 10(3): e0121363(12pp).
    21. Werfalli, M., Raubenheimer, P.J., Engel, M.E., Peer, N., Kalula, S.Z., Kengne, A.P. and Levitt, N. 2015. Effectiveness of community-based peer-led diabetes self-management programmes (COMP-DSMP) for improving clinical outcomes and quality of life of adults with diabetes in primary care settings in low and middle-income countries (LMIC): a systematic review and meta-analysis. BMJ Open, 5: e007635(4pp).
    22. Wicht, K., Combrinck, J.M., Smith, P.J. and Egan, T.J. 2015. Bayesian models trained with HTS data for predicting b-haematin inhibition and in vitro antimalarial activity. Bioorganic & Medicinal Chemistry, 23: 5210-5217.
    23. Wilhelm, A., Kendrekar, P., Noreljaleel, A., Abay, E., Bonnet, S.L., Wiesner, L., De Kock, C., Swart, K.J. and van der Westhuizen, J. 2015. Syntheses and in vitro antiplasmodial activity of aminoalkylated chalcones and analogues. Journal of Natural Products, 78: 1848-1858.
    24. Wilkinson, K., Walker, N.F., Meintjes, G., Deffur, A., Nicol, M.P., Skolimowska, K.H., Matthews, K., Tadokera, R., Seldon, R.R., Maartens, G., Rangaka, M.X., Besra, G.S. and Wilkinson, R.J. 2015. Cytotoxic mediators in paradoxical HIV-tuberculosis immune reconstitution inflammatory syndrome. Journal of Immunology, 194: 1748-1754.
    25. Wilkinson, R.J. 2015. Towards host-directed therapies for tuberculosis. Nature Reviews Drug Discovery, 14(8): 511–512.
    26. Williams, P., Petersen, Z., Sorsdahl, K., Mathews, C., Everett-Murphy, K. and Parry, C. 2015. Screening and brief interventions for alcohol and other drug use among pregnant women attending midwife obstetric units in Cape Town, South Africa: a qualitative study of the views of health care professionals. Journal of Midwifery & Womens Health, 60: 401-409.
    27. Yako, Y.Y., Echouffo-Tcheugui, J.B., Balti, E.V., Matsha, T.E., Sobngwi, E., Erasmus, R.T. and Kengne, A.P. 2015. Genetic association studies of obesity in Africa: a systematic review. Obesity Reviews, 16: 259-272.
    28. Yako, Y.Y., Madubedube, J.H., Kengne, A.P., Erasmus, R.T., Pillay, T. and Matsha, T.E. 2015. Contribution of ENPP1, TCF7L2, and FTO polymorphisms to type 2 diabetes in mixed ancestry ethnic population of South Africa. African Health Sciences, 15(4): 1149-1160.
    29. Youkee, D., Brown, C.S., Lilburn, P., Shetty, N., Brooks, T., Simpson, A., Bentley, N., Lado, M., Kamara, T.B., Walker, N.F. and Johnson, O. 2015. Assessment of environmental contamination and environmental decontamination practices within an Ebola holding unit, Freetown, Sierra Leone. PLoS One, 10(12): e0145167(10pp).
    30. Yulyana, y., Ho, I.A., Sia, K.C., Newman, J.P., Toh, X., Endaya, B.B., Chan, J.K.Y., Gnecchi, M., Huynh, H., Chung, A.Y.F. and Lim, K. 2015. Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling. Molecular Therapy, 23(4): 746-756.
    31. Zar, H.J., Bateman, E.D., Potter, P.C., Bousquet, J., Schunemann, H.J. and Fonseca, J. 2015. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy, 70: 1372-1392.
    32. Zemlin, A.E., Matsha, T.E., Kengne, A.P. and Erasmus, R.T. 2015. Derivation and validation of an HbA1c optimal cutoff for diagnosing prediabetes in a South African mixed ancestry population. Clinica Chimica Acta, 448: 215-219.
    33. Zuhlke, L., Engel, M.E., Karthikeyan, G., Rangarajan, S., Mackie, P., Cupido, B.J., Mauff, K., Islam, S., Joachim, A., Daniels, R., Francis, V., Ogendo, S., Gitura, B., Mondo, C., Okello, E., Lwabi, P., Al-Kebsi, M.M., Hugo-Hamman, C., Sheta, S.S., Haileamlak, A., Daniel, W., Goshu, D.Y., Abdissa, S.G., Desta, A.G., Shasho, B.A., Begna, D.M., ElSayed, A., Ibrahim, A.S., Musuku, J., Bode-Thomas, F., Okeahialam, B.N., Ige, O., Sutton, C., Misra, R., Fadl, A.A., Kennedy, N., Damasceno, A., Sani, M., Ogah, O., Olunuga, T., Elhassan, H.M.M., Mocumbi, A.O., Adeoye, A.M., Mntla, P., Ojji, D., Mucumbitsi, J., Teo, K., Yusuf, S. and Mayosi, B.M. 2015. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). European Heart Journal, 36: 1115-1122.
    34. Zuhlke, L., Engel, M.E., Watkins, D.A. and Mayosi, B.M. 2015. Incidence, prevalence and outcome of rheumatic heart disease in South Africa: a systematic review of contemporary studies. International Journal of Cardiology, 199: 375-383.
    35. Zumla, A., Maeurer, M., Moll, G. and Mayosi, B.M. 2015. Host-directed therapies for tuberculous pericarditis. International Journal of Infectious Diseases, 32: 30-31.


Peer-reviewed Journals (not DoE Accredited)

  • A - E

    1. Abrahams-Gessel, S., Denman, C., Montano, C.M., Gaziano, T., Levitt, N.S., Rivera-Andrade, A., Carrasco, D.M., Zulu, J., Khanam, M.A. and Puoane, T. 2015. The training and fieldwork experiences of community health workers conducting population-based, noninvasive screening for CVD in LMIC. Global Heart, 10(1): 45–54.
    2. Abrahams-Gessel, S., Denman, C., Montano, C.M., Gaziano, T.A., Levitt, N., Rivera-Andrade, A., Carrasco, D.M., Zulu, J., Khanam, M.A. and Puoane, T. 2015. Training and supervision of community health workers conducting population-based, noninvasive screening for CVD in LMIC: Implications for scaling up. Global Heart, 10(1): 39-44.
    3. Aleckovic-Halilovic, M., Nel, D. and Woywodt, A. 2015. Granulomatous interstitial nephritis: a chameleon in a glabalized world. Clinical Kidney Journal, 8(5): 511–515.
    4. Aminde, L., Dzudie, A., Takah, N.F., Ngu, K.B., Sliwa, K. and Kengne, A.P. 2015. Current diagnostic and treatment strategies for Lutembacher syndrome: the pivotal role of echocardiography. Cardiovascular Medicine, 5(2): 122–132.
    5. Benatar, S.R. 2015. Explaining and responding to the Ebola epidemic. Philosophy, Ethics, and Humanities in Medicine, 10(5): 1-3.
    6. Boateng, M., Corrigall, A.V., Sturrock, E.D. and Meissner, P.N. 2015. Characterisation of the flavin adenine dinucleotide binding region of Myxococcus xanthus protoporphyrinogen. Biochemistry and Biophysics Reports, 4: 306–311.
    7. Botha, J. and Thomson, S.R. 2015. The Chicago classification simplified. The South African Gastroenterology Review, 2: 19-22.
    8. Burton, R., Giddy, J. and Stinson, K. 2015. Prevention of mother-to-child transmission in South Africa: an ever-changing landscape. Obstetrics Medicine, 8(1): 5-12.
    9. Chin, A., Healey, J.S., Ribas, C. and Nair, G.M. 2015. Delayed AICD therapy and cardiac arrest resulting from undersensing of ventricular fibrillation in a subject with hypertrophic cardiomyopathy-a case report. Indian Pacing and Electrophysiology Journal, 15: 121-124.
    10. Chughlay, M.F., Kramer, N., Werfalli, M., Spearman, W., Engel, M.E. and Cohen, K. 2015. N-acetylcysteine for non-paracetamol drug-induced liver injury: A systematic review protocol. Systematic Reviews, 4(84): 1-6.
    11. de Jager, C.A. 2015. Knowledge, attitudes and beliefs about dementia in an urban Xhosa-speaking community in South Africa. Advanced in Alzheimer's Disease, 4: 21-36.
    12. de Vries, J., Abayomi, A., Littler, K., Madden, E., McCurdy, S.A., Oukem-Boyer, O.O.M., Seeley, J., Staunton, C., Tangwa, G., Tindana, P. and Troyer, J. 2015. Addressing ethical issues in H3Africa research the views of research ethics committee members. The HUGO Journal, 9(1): 1-4.
    13. Essouma, M. and Noubiap, J.J. 2015. Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. Biomarker Research, 3(24): 1–11.
    14. Everett-Murphy, K. and Webb, D. 2015. Brief behavioural change counselling and motivational interviewing to elicit healthy behavioural change. South African Journal of Diabetes, 8(4): 26-29
  • F - J

    1. Fokom-Domgue, J., Combescure, C., Fokom-Defo, V., Tebeu, P.M., Vassilakos, P., Kengne, A.P. and Petigna, P. 2015. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. The BMJ, 351: h3084(11pp).
    2. Gabriel, M.S., Sonderup, M.W., Locketz, M.L., Bernon, M., Thomson, D., Gogela, N., Du Toit, J.M., Muller, E. and Spearman, W. 2015. A toxic brew. The South African Gastroenterology Review, 13(2): 30-32.
    3. Guewo-Fokeng, M., Sobngwi, E., Atogho-Tiedeu, B., Donfack, O.S., Noubiap, J.J., Ngwa, E.N., Mato-Mofo, E.P., Fosso, P.P., Djahmeni, E., Djokam-Dadjeu, R. and Evehe, M.B. 2015. Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon. Journal of Diabetes and Metabolic Disorders, 14(26): 1-5.
    4. Johnson, T.D., Grainger Gasser, A., Boardman, C., Remenyi, B., Wyber, R. and Mayosi, B.M. 2015. The 5 x 5 path toward rheumatic heart disease control outcomes from the third rheumatic heart disease forum. Global Heart, 10(1): 75-78.
  • K - O

    1. Kakande, B., Isaacs, T., Muloiwa, R., Dlamini, S.K. and Lehloenya, R.J. 2015. Case Report: Stevens-Johnson syndrome following a single double dosing of nevirapine-containing regimen once in an HIV-infected woman on long-term antiretroviral therapy. F1000 Research, 4: 175(5pp).
    2. Katsidzira, L. and Thomson, S.R. 2015. The epidemiology of colorectal cancer in South Africa: Room for improvement. The South African Gastroenterology Review, 13(2): 25-28.
    3. Lowe, D.M., Bangani, N.M., Goliath, R.T., Kampmann, B., Wilkinson, K., Wilkinson, R.J. and Martineau, A. 2015. Effect of antiretroviral therapy on HIV-mediated impairment of the neutrophil antimycobacterial response. Annals of the American Thoracic Society, 12(11): 1627-1637.
    4. Manohar, S., Pavan, V.S., Taylor, D., Kumar, D., Ponnan, P., Wiesner, L. and Rawat, D.S. 2015. Highly active 4-aminoquinoline-pyrimidine based molecular hybrids as potential next generation antimalarial agents. The Royal Society of Chemistry, 5: 28171-28186.
    5. Marais, S. and Wilkinson, R.J. 2015. Are the present doses of anti Tubercular drugs adequate for severe disease? EBioMedicine, 2: 1572–1573.
    6. Masconi, K., Echouffo-Tcheugui, J.B., Matsha, T.E., Erasmus, R.T. and Kengne, A.P. 2015. Predictive modeling for incident and prevalent diabetes risk evaluation. Expert Review of Endocrinology and Metabolism, 10(3): 277-284.
    7. Masconi, K., Matsha, T.E., Echouffo-Tcheugui, J.B., Erasmus, R.T. and Kengne, A.P. 2015. Reporting and handling of missing data in predictive research for prevalent undiagnosed type 2 diabetes mellitus: A systematic review. EPMA Journal, 6(7): 1-11.
    8. Mbuli, L., Mapiye, D. and Okpechi, I.G. 2015. Lupus nephritis is associated with poor pregnancy outcomes in pregnant SLE patients in Cape Town: A retrospective analysis. Pan African Medical Journal, 22: 365(10pp).
    9. Moorhouse, M., Bekker, L., Black, V., Conradie, F., Harley, B., Howell, P., Maartens, G., Papavarnavas, T., Rebe, K., Sorour, G., Venter, W.D. and Wallis, C. 2015. Guideline on the management of occupational andnon-occupational exposure to the humanimmunodeficiency virus and recommendations forpost-exposure prophylaxis: 2015 Update. South African Journal of HIV Medicine, 16(1): 399(14pp).
    10. Muloiwa, R., Kagina, B., Engel, M.E. and Hussey, G.D. 2015. The burden of pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunization (EPI) in 1974: a systematic review protocol. Systematic Reviews, 4: 62(7pp).
    11. Nansseu, J.R. and Noubiap, J.J. 2015. Aspirin for primary prevention of cardiovascular disease. Thrombosis Journal, 13(38): 1-10.
    12. Nashidengo, P.M., Gool, F. and Thomson, S.R. 2015. Asymptomatic cholelithiasis in diabetes mellitus to operate or not to operate that is the question. The South African Gastroenterology Review, 13(2): 13-16.
    13. Ngwa, E.N., Sobngwi, E., Atogho-Tiedeu, B., Noubiap, J.J., Donfack, O.S., Guewo-Fokeng, M., Mofo-Mato, E.-P., Fosso, P.P., Djahmeni, E., Djokam-Dadjeu, R., Evehe, M.B., Aminkeng, F., Mbacham, W. and Mbanya, J.C. 2015. Association between the rs12255372 variant of the TCF7L2 gene and obesity in a Cameroonian population Obesity. BMC Research Notes, 8: 717(6pp).
    14. Noubiap, J.J., Naidoo, J. and Kengne, A.P. 2015. Diabetic nephropathy in Africa: A systematic review. World Journal of Diabetes, 6(5): 759–773.
    15. Noubiap, J.J., Nasseu, J.R., Ndoula, S.T., Wang, B., Jingi, A.M., Bigna, J.J.R., Aminde, L., Youmbi, R.A. and Fokom-Domgue, J. 2015. Prevalence and correlates of HIV-risky sexual behaviors among students attending the medical and social welfare center of the University of Maroua, Cameroon. BMC Research Notes, 8: 635(11pp).
    16. Omar, F., Dave, J.A., King, J.A., Levitt, N. and Pillay, T. 2015. High Molecular Weight (HMW): Total adiponectin ratio is low in HIV-infected women receiving protease inhibitors. BMC Clinical Pathology, 14(46): 1-7.
    17. Orrell, C., Felizarta, F., Nell, A., Kakuda, T., Lavreys, L., Nijs, S., Tambuyzer, L., Van Solingen-Ristea, R. and Tomaka, F. 2015. Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients. AIDS research and Treatment, 2015: 938628(11pp).
  • P - T

    1. Pasipanodya, J.G., Mubanga, M., Ntsekhe, M., Pandie, S., Magazi, B.T., Gumedze, F.N., Myer, L., Gumbo, T. and Mayosi, B.M. 2015. Tuberculous Pericarditis is multibacillary and bacterial burden driveshigh mortality. EBioMedicine, 2: 1634-1639.
    2. Peer, N. 2015. The converging burdens of infectious and non-communicable diseases in rural-to-urban migrant Sub-Saharan African populations: a focus on HIV/AIDS, tuberculosis and cardio-metabolic diseases. Tropical Diseases, Travel Medicine and Vaccines, 1(6): 1-8.
    3. Priso, E.B., Njamen, T., Tchente, C., Kana, A.J., Landry, T., Tchawa, U.F.N., Hentchoya, R., Beyiha, G., Halle, M.P., Aminde, L. and Dzudie, A. 2015. Trend in admissions, clinical features and outcome of preeclampsia and eclampsia as seen from the intensive care unit of the Douala General Hospital, Cameroon. Pan African Medical Journal, 21: 103(11pp).
    4. Shaboodien, G., Watkins, D.A., Pillay, K., Beighton, P., Heckmann, J.M. and Mayosi, B.M. 2015. Limb-girdle weakness in a marfanoid man: distinguishing calpainopathy from Becker's muscular dystrophy. Practical Neurology, 15: 152-154.
    5. Steyn, N., Mchiza, Z.J.-R. and Kengne, A.P. 2015. Future challenges for pediatric diabetes management in developing countries: lessons from Africa. Expert Review of Endocrinology and Metabolism, 10(1): 75-86
  • U - Z

    1. Walker, N.F., Scriven, J., Meintjes, G. and Wilkinson, R.J. 2015. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV/AIDS - Research and Palliative Care, 7: 49-64.
    2. Watermeyer, G., Epstein, D. and Kassianides, C. 2015. Recommendations on the use of anti-TNF's in adults with Inflammatory Bowel Disease. The South African Gastroenterology Review, 3(21): 21-24.